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ABSTRACT 
Viruses are obligate intracellular parasites and, as a consequence of many years of co-
evolution with their hosts, have evolved genes/strategies to manipulate and/or evade host cell 
biology and immune responses. Many of these viral evasion genes code for proteins that are 
non-essential for virus replication in vitro. They may, however, be considered as valuable 
“ready made tools” to extend, explore and manipulate the regulation of the basic cellular 
processes that they manipulate. 
African swine fever virus (ASFV) is a devastative acute pathogen of domestic pigs, 
principally in Africa where due to progressive urbanization and informal pig rearing, 
endemicity is growing. 
In its wild life hosts, both vertebrate (warthog and bush pig) and invertebrate (soft tick), 
however, the virus has evolved many genes to escape the full ferocity of the host immune 
response and is non-pathogenic. This project has focused on one such strategy, specifically, 
the ASFV gene I329L, which has been demonstrated to inhibit TLR signaling. Two important 
future possibilities have been defined by this work: 
1) The demonstration that I329L is a non-essential virus gene will permit construction of an 
I329L deletion-mutant virus and work towards this has commenced with the successful 
subcloning of the flanking regions of I329L into the necessary transfer vector. The I329L 
deletion virus will further our understanding of the role of I329L in the pathogenesis of the 
ASFV infection and may justify the testing of an I329L deletion mutant as a vaccine. 
2) The demonstration that I329L functions in mouse macrophages and the subsequent 
construction of a macrophage restricted I329L transgenic mouse will provide an in vivo 
system to determine the role of I329L in healthy and infected macrophages. 
Key words: African Swine Fever virus, I329L, macrophages, TLR, immune evasion. 
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SUMÁRIO 
Os Vírus são parasitas intracelulares que como consequência de evoluírem em conjunto com 
os seus hospedeiros, desenvolveram estratégias/genes de manipulação e/ou evasão das células 
e resposta imunitária do hospedeiro. Muitos destes genes de evasão codificam proteínas que 
são não essenciais para a replicação do vírus in vitro. Podem, no entanto ser consideradas 
ferramentas úteis no estudo e manipulação da regulação dos processos celulares que 
manipulam. O vírus da Peste Suína Africana (PSA) é um patogénio que causa doença aguda 
em porcos domésticos, principalmente em África, onde o seu estado endémico é cada vez 
maior devido principalmente a uma urbanização progressiva e também à criação doméstica de 
porcos. No entanto, nos seus hospedeiros selvagens tanto vertebrados como invertebrados, o 
vírus desenvolveu estratégias e genes que lhe permitem evadir fortes respostas imunitárias, 
sendo não-patogénico. Este projecto foca-se no estudo de um gene do ASFV, o I329L, no 
qual já foram previamente feitos estudos no nosso laboratório que demonstraram que inibe a 
via de sinalização TLR. Foram definidas duas abordagens para o estudo deste gene neste 
projecto: 1) A demonstração de que o I329L é um gene viral não essencial que permite a 
construção de um vírus de delecção mutante, tendo o trabalho neste sentido começado pela 
clonagem bem sucedida das regiões que flanqueiam o gene no vector de transferência 
apropriado. O vírus mutante para o I329L permitirá a melhor compreensão das funções deste 
gene na patogenicidade da infecção e poderá justificar a construção de uma vacina mutante 
por delecção. 2) A demonstração de que o I329L mantém a sua função em macrófagos de 
ratinho e a subsequente construção de um ratinho transgénico com expressão de I329L restrita 
a macrófagos, proporcionam um sistema in vivo que permitirá avaliar o papel do I329L em 
macrófagos infectados e não infectados.  
Palavras chave: Peste Suína Africana, I329L, macrófagos, TLR, evasão imune. 
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1) GENERAL INTRODUCTION 
 
1.1) INTRODUCTION 
Viruses are among the most common and numerous microorganisms on Earth, having the 
ability to infect all types of cellular organisms. They are obligate intracellular parasites that 
can replicate independently of cell’s chromosomes but not of the cells themselves, which 
means they need a host. Their replication may be destructive to the host cell, an aspect that 
accounts for the fact that some viruses are agents of disease. Viruses co-evolve with their 
hosts which allows them to develop an intimate relationship with intracellular processes and, 
in turn, provide them with successful replication, assembly and transmission to new 
susceptible hosts. Viruses can also provide important new properties to host cells that are 
inherited when the host cells divide. These changes may be deleterious to the hosts, for 
example cervical cancer caused by the human papillomavirus, HPV. 60. 
 
1.1.1) Virus inhibition of the Innate immune response 
The immediate, or innate, immune response is multicomponent and serves to isolate and 
contain an initial virus infection. 
 
1.1.1.1) Virus inhibition of the complement system 
Viruses have evolved strategies for protection against complement activation and these can be 
classified in three general categories: 1) virus proteins which are homologous to mammalian 
complement regulatory proteins, 2) virus proteins which have no sequence homology, but 
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share functional characteristics with complement regulatory proteins and 3) viruses that 
incorporate host complement regulatory proteins into their envelope during virus maturation.  
Some examples come from inflammation modulatory protein (IMP), a complement inhibitor 
of cowpox virus (CPV) that inhibits the production of macrophage chemoattractant factors 
C3a and C5a 53. In doing so, no tissue damage occurs at the site of infection. 
Other viruses, like herpes simplex virus (HSV) -1 and -2 and mouse cytomegalovirus 
(MCMV) encode Fc receptors; antibodies that bind either the virus particle or the infected cell 
might do it at the Fc region and will not activate phagocytes and complement 27. 
 
1.1.1.2) Virus inhibition of interferon responses 
The interferon response to virus infection is complex and multicomponent and begins almost 
as a virus enters a cell, where its induction activates the infected cell to an “anti-virus” state. 
Subsequent induction of secretion of interferons (IFNs) then alerts surrounding cells to the 
virus infection and these then, in turn, become activated to an anti-virus state. In addition, 
IFNs also play a part in the homeotasis of immune responses. The importance of the IFN 
response in resistance to viruses is emphasised by 1) The large number of virus genes that 
have been evolved for subversion of both the type I (IFNα and IFNβ) and the type II (IFNγ) 
IFNs and 2) The fact that mice with IFN responses deleted by knock-out of IFN receptors 
succumb to normally non-fatal virus infections 17, 80, 51. 
 
1.1.1.3) Virus inhibition of apoptosis 
Apoptosis is a process that is a prominent feature of all multicellular organisms and of some 
unicellular organisms such as yeasts, and as been highly conserved throughout evolution. 
Apoptosis can be triggered by a variety of inducers, including irradiation, cell-cycle 
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inhibitors, infectious agents like viruses and ligands of the TNF family. It is important in 
development and normal cell turnover processes, and also plays a key role in the innate 
response to and control of viral infections. Although one can consider apoptosis as an innate 
cellular response to limit viral propagation, later in the replicative cycle of the virus, apoptosis 
might facilitate virus dissemination. and that is why viral apoptosis regulators fall into two 
types: 1) Inhibitor proteins that function by blocking or delaying the onset of apoptosis to 
allow the viral replication cycle to be completed, and 2) Inducer proteins that stimulate 
apoptosis either by inappropriately interfering with cell cycle progression or by assisting virus 
release and dissemination.  
The Bcl-2 proteins regulate ion permeability and membrane potential of mitochondria and 
inhibit the release of cytochrome c, which powerfully activates effector caspases, a family of 
cytosolic aspartate-specific cysteine proteases (CASPASES), which are crucial participants in 
the apoptotic cascade. Numerous viruses modulate the activity of bcl-2 proteins in the cell, 
either encoding viral homologues or changing protein levels. For example, Epstein-Barr virus 
(EBV), Human herpes virus-8 (HHV-8), African swine fever virus (ASFV), HSV, Murine 
herpes virus-68 (MHV-68), alcelaphine herpesvirus-1, adenovirus, and Bovine herpesvirus 
type 4 (BHV-4) code bcl-2 family homologues.  
Some viruses have developed strategies to counteract hyperreactive oxides before they can 
exert their toxic effects on viral molecules or trigger a deleterious apoptotic response. These 
strategies protect viruses against attack by oxidative stress 18. 
 
1.1.1.4) Virus inhibition of Natural Killer cells 
NK cells are important effector components of the innate immune system and participate in 
the initial defence against viral infection, both by cellular cytotoxicity and by the production 
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of inflammatory cytokines. These cells are not MHC restricted and do not express T cell 
receptors. They are usually prevented from killing their targets by inhibitory signals provided 
through interaction of receptors on NK cells with self-MHC molecules on the surface of 
potential target cells 42. The missing-self hypothesis proposes that NK cells recognize the 
absence of cell surface-expressed self-MHC class I product as a signal for attack and 
destruction of a target cell 59.  
Some viruses might escape detection by NK cells through the production of surface-expressed 
MHC class I homologs that do not bind peptides, as indeed happens in both mouse and human 
CMV.  
 
1.1.1.5) Virus inhibition of cytokines and chemokines 
Cytokines are secreted polypeptides that coordinate inflammation, cellular activation, 
proliferation, differentiation and chemotaxis, and orchestrate the induction and maintenance 
of innate and adaptive antiviral responses. Therefore, targeting their function is of immediate 
value and contributes to virulence of viral pathogens. Several cytokines are of particular 
importance and are frequently targeted by viruses; these include IL-1, IL-12, TNF, IFN-α and 
-β, IFN-γ, and a number of chemokines.  
Chemokines (CKs) are small disulfide-linked cytokines that are chemoattractants to 
leukocytes. They are divided in four different subfamilies according to conserved structural 
features, and their effects on leukocytes are mediated by changes in intracellular calcium and 
activation of second messenger systems, following binding of chemokines to G protein 
coupled receptors (GCRs) with seven-transmembrane regions 45.  
One interesting mechanism some viruses have developed, namely large DNA viruses, is the 
mimicry of cytokines and their receptors. Herpesviruses secrete homologues of IL-16 and Il-
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17, which could increase proliferation of the cells that are the targets of viral replication 4. 
Poxviruses secrete cytokine receptors or cytokine binding proteins and these proteins were 
originally identified as homologues of TNFR, IL-1R and IFN-γR. Since then, secreted 
proteins that bind IFN-α and -β, CKs and IL-2 without any sequence homology have been 
described 4, 82. 
 
1.1.2) Virus inhibition of Acquired humoral and cellular immunity 
Antiviral immunity results from a combination of both cell mediated and antibody and 
complement immune responses.  
The humoral immune, or antibody (Ab), responses will impede viruses from establishing an 
infection. Typically, protective immunoglobulins (Igs) will be secreted, bind to the virus 
surface and block interaction with cellular receptors. These Ab-virus complexes can then be 
recognized and eliminated by cells of the phagocytic lineage, which express Fc receptors. 
Also, Fc receptors will instruct NK cells to lyse Ab coated infected cells (Ab-dependent 
cellular cytotoxicity).  
 
1.1.2.1) Virus inhibition of antibody responses 
Receptors for the constant part of the immunoglobulin G (IgG), known as Fc receptors 
(FcγRs) are present on many mammalian hamatopoietic cells, such as monocytes, 
macrophages, neutrophils, eosinophils, platelets, B cells and certain classes of T cells 6. FcγRs 
constitute an important bridge between the humoral and cellular immune systems because 
interaction of the IgG Fc domain with cell surface FcγRs results in the triggering of many 
effector functions, such as phagocytosis, cell proliferation, cell activation or inhibition, Ab 
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dependent cellular cytotoxicity (ADCC) and release of cytokines and inflammatory 
mediators. This is why some viruses express IgG Fc receptor homologues to bypass the 
effector consequences of Ab binding. 
 
1.1.2.2) Virus inhibition of MHC class I presentation 
Once inside a cell, viral mRNAs are translated using the cellular translation machinery. Like 
other proteins, cytosolic viral gene products are degraded by cellular proteases, as part of 
normal protein turnover among them, a multi-subunit catalytic protease complex known as 
the proteosome 26. Once degraded, the viral antigenic peptides are transferred to the lumen of 
the endoplasmic reticulum (ER) by the transporter associated with antigen presentation (TAP) 
and “loaded” into the peptide binding groove of the MHC I complex, a molecule composed of 
a MHC I heavy chain and a β
2
m microglobulin light chain 40. Molecules of MHC I loaded 
with viral peptide are transported from the ER, through the Golgi apparatus to the plasma 
membrane, where they become available for surveillance by antigen-specific receptor CD8
+ 
T 
cells, or CTLs, 90, 47. Upon recognition of the MHC I-peptide complex on the plasma 
membrane of the virally infected cell or of a professional APC, the interaction between the T 
cell receptor complex and the class I molecule-peptide complex, activates the T cell to a host 
antiviral immunologic response.  
Once the CTL precursors are activated, they proliferate and differentiate into effector cells. 
Viruses that attenuate or block viral peptide presentation on the surface of the infected cell 
could escape detection by CTLs. Several viruses use this strategy, both transcriptionally and 
post-transcriptionally, and viruses have evolved multiple mechanisms to interfere with 
antigen presentation, emphasising the importance of CTL responses in controlling virus 
infections.  
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1.1.2.3) Viral inhibition of MHC class II presentation 
When pathogens enter the endocytic pathway by phagocytosis or receptor-mediated 
endocytosis, many of their proteins are degraded into antigenic peptides, mostly by 
endosomal proteases. These antigenic peptides are presented and integrated into MHC class II 
molecules, typically expressed by professional APCs, the macrophages, dendritic cells (DCs), 
and also B cells. Once transported to the cell membrane, they are presented to CD4
+ 
T cells, 
which then become activated 104, 74). Expression of MHC class II molecules can also be 
induced in a variety of other cell types. The activated CD4
+ 
T cells will then stimulate the 
development of CTLs and also help mount a serological antiviral response against the invader 
46. 
 
1.1.3) The African Swine Fever Virus 
1.1.3.1) Pathogenesis and epidemiology 
The African Swine Fever Virus (ASFV) was first observed in domestic pigs (Sus scrofa), in 
Kenya 67, 68 causing spleen enlargement and lethal haemorrhagic disease accompanied by 
extensive lymphoid tissue destruction due to apoptosis 33, 50, 72, 73, 85. The mortality rates due to 
the disease, were at this point of 100% 67, 68. Other immunological changes include 
hypergammaglobulinaemia, as well as reduced responses to lectins by T cells from infected 
animals 81, 63. 
The virus persists in sub-Saharan Africa in its natural hosts, the bush pig, Potamochoerus 
porcus, and the warthog, Phacochoerus aethiopicus, but with total absence of clinical 
symptoms 29, 52. It also infects an invertebrate, the soft tick, Ornithodoros moubata and 
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Ornithodoros erraticus, that inhabits warthog burrows (Figure 1). The soft tick parasites the 
warthog, thus creating a cycle of infection that maintains the virus in Africa. The virus is well 
adapted to these hosts producing infections that can persist for months or years. The soft tick 
can transmit the virus both to wildlife host and domestic pigs; porcine hosts can pass the virus 
between themselves through direct contact 52, 102, 105. The bush pig and warthog are thought to 
be the natural reservoir of ASFV since they show no clinical signs of disease once infected 
with virulent and haemorrhagic isolates of the virus, that kill domestic pigs within 5-7 days 
post infection 52, 72, 73. 
A B C
D E
 
Figure 1 – Swine hosts of ASFV and vectors of infection. 
(A) domestic pig, Sus scrofa, (B) bush pig, Potamochoerus porcus, (C) warthog, 
Phacochoerus aethiopicus, (D) the soft ticks Ornithodoros moubata and 
Ornithodoros erraticus (E) domestic pig killed by ASFV with the characteristic 
haemorrhagic syndrome 108, 109. 
 
After the original report of ASFV in Kenya in the 1920s, the virus was then detected in most 
sub-Saharan countries, where it is still endemic. It started spreading and it escaped from 
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Africa evolving towards less virulent strains that cause very attenuated and chronic forms of 
the disease 105. Once it reached Europe through infected pork products, it was detected in 
Portugal and Spain in 1957, then again in 1960 where it remained endemic until the 1990s. 
Other European countries have been affected as well the Caribbean (Cuba, Dominican 
Republic and Haiti), and Brazil 102. The disease has been eradicated from most of these 
countries outside Africa, with the exception of Sardinia where it still remains since it 
appeared in 1982. More recently, ASF has led to major economic losses after spreading 
through many West African countries, as is the case of Madagascar where it first appeared in 
1998. Less virulent isolates have also been described in domestic pigs, as they cause a 
reduced mortality and, in some cases, chronic infections. Pigs that recover from this condition 
may remain persistently infected for long periods, thus providing a reservoir for infecting 
healthy pigs 55, 96, 101, 102. 
 
The virus infects cells of the monocytic lineage, mainly the central cell of the innate immune 
response, the macrophage, both in vivo and in vitro. One report 94 described infection of 
endothelial cells in vitro. Depending on the viral strain, the virus codes between 100-150 
polypetides. About 40 of these have been described as being incorporated into the viral 
particle. A further 16 have been identified as enzymes and 30-40 as possible host 
modification genes 35, 52. In order to infect and replicate in macrophages, in vivo, the virus has 
evolved strategies to modulate and/or interfere with the host immune response to infection. 
During disease, circulating lymphocytes and neutrophils show reduced numbers in acute 
infections 24, 98, 103. This is typically accompanied by hypergammaglobulinaemia. Although 
as initially suggested by some studies 97, 98, there are no classical neutralizing antibodies 
produced during viral infection, antibodies may play a role in the protective immune response 
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against ASFV 16, 107, 71, 37). For instance, serum from animals infected with a low virulence 
viral isolate provided protection from infection with virulent ASFV isolates and against low 
passage tissue culture adapted viral variants 107. Also, the same protective or neutralizing 
activity for several virulent isolates was observed when testing a monoclonal antibody (mAb) 
that reacts against a 72 kDa ASFV protein 16. However, neither the immune pig sera, nor the 
anti-72 kDa ASFV protein mAb neutralized high passage tissue culture adapted ASFV 
isolates. It has been suggested that the adaptation of ASFV isolates to tissue culture 
conditions may be associated with the loss of determinants important for virus neutralization 
107.  
Another important observation in reinforcing the existence of protective serological immunity 
was that after passive transfer of anti-ASFV serum to pigs, these animals were partially 
protected against a highly pathogenic virus isolate. Not only there was a delay in the 
appearance of viraemia and a reduction in the virus titers, but some of the animals presented 
no clinical symptoms after secondary challenge with the pathogenic isolate. In contrast, in the 
control group, symptoms and death occurred 4 days after the challenge 71. 
 
In spite of evident need, no vaccine is yet available, and disease control relies on rapid 
diagnosis, implementation of sanitary measures and movement restrictions. Diagnosis of 
disease poses a major complication due to the varying pathogenesis caused by different 
isolates, the similarity to other viral haemorrhagic fevers and the need to transport highly 
infectious samples to labs for testing. This policy is difficult to implement in many African 
countries since it requires good infrastructures that are lacking in many of these countries. 
ASF continues to pose a major threat to pig farming worldwide. An effective vaccine would 
help to control a major pathogen of pigs in large endemic areas in Africa, provide an 
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alternative to mass slaughter of animals and protect non-endemic from accidental entry of the 
virus. 
 
1.1.3.2) Virus structure, entry, replication cycle and assembly 
ASFV is a large icosahedral virus and the only known member of the Asfarviridae family, 
genus Asfivirus 28, 29. It has a linear double-stranded DNA genome with structural features 
similar to iridoviruses and genomic organization similar to poxviruses 29, 52. The virus 
replicates and assembles in the cytoplasm and encodes enzymes and factors that are required 
for replication and transcription of the virus genome. Depending on the virus isolate, the 
genome varies between 170 and 190 kb 15, and sequencing of the complete genome of the 
Spanish tissue culture adapted isolate, Ba71v 105, of ASFV suggests that this virus may 
encode 151 major open reading frames (ORFs) 52. 
 
Extracellular ASFV particles have a diameter of approximately 200 nm and are formed by a 
DNA-containing nucleoid surrounded by three layers: an internal membrane, an icosahedric 
capsid, and an external membrane (Figure 2) 19. The virus enters cells through receptor 
mediated endocytosis and is released from endocytic vesicles into the cytoplasm. This occurs 
through a mechanism of fusion of the virus envelope with the endocytic vesicles 2, 14, 93. 
Studies involving the use of antibodies against virus proteins such as p12, p54, p72 and p30 
have shown that these have important roles in the process of binding of the virus (p12, p72, 
p54) or internalisation (p30) 16, 35, 36, 37, 38. 
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Figure 2 – African Swine Fever virus structure. ASFV particles have a complex 
multi-layered structure. The nucleoprotein core structure is 70 to 100 nm in diameter. 
The nucleoprotein core is surrounded by a core shell and an internal envelope onto 
which the icosahedral capsid is assembled. The capsid is 170 to 190 nm in diameter. 
Although earlier reports suggested that this internal membrane consisted of a collapsed 
double membrane layer it has also been suggested that only one membrane layer is 
present. (Photograph from Linda Dixon, Institute for Animal Health, Pirbright 
Laboratory, UK) 
 
Early virus mRNA transcription begins in the cytoplasm and is followed by virus replication 
through the use of host enzymes that are packaged in virions. These early transcripts encode 
proteins that include important enzymes such as DNA polymerase required for virus genome 
replication that occurs in the cytoplasm as early as 6 hours post infection. Late transcripts, on 
the other hand, largely encode structural proteins. 
 
1.1.3.3) TLR signalling pathway 
In vertebrates, the innate immune system is essential for host defence, as it constitutes the first 
line of defence against invading and potentially pathogenic microorganisms. 
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The host cells express various pattern recognition receptors (PRRs) that recognize pathogen-
associated molecular patterns (PAMPs). For example, many pathogens contain carbohydrates 
and peptide derivatives, as well as methylated DNA, which the host can recognize as “non-
self”. Once there is recognition of PAMPs by PRRs, an activation of intracellular pathways 
occurs, that leads to the induction of inflammatory cytokines, chemokynes, interferons (IFNs) 
and also upregulation of co-stimulatory molecules 49.  
 
Innate immune receptors may be transmembrane signalling receptors such as Toll-like 
receptors (TLRs), or soluble components that opsonize microorganisms labelling them for 
recognition by complement receptors, Fc receptors or integrins. These receptors may trigger a 
variety of responses depending on the receptor and cell type: 1) through the mediation of 
microbe internalisation by phagocytic cells; 2) activation of antimicrobial mechanisms such 
as production of reactive nitrogen and oxygen molecules or species; and 3) stimulation of the 
production of inflammatory cytokines and chemokines that activate other immune cells 92. 
In mammals, TLRs serve as key PRRs and play a crucial role in the induction of innate 
immune responses and consequent development of adaptative immune responses 49. 
The Toll receptor was originally identified in Drosophila as an essential receptor for the 
establishment of the dorso-ventral pattern in developing embryos. In fact, Hoffmann and 
colleagues demonstrated, in 1996, that Toll-mutant flies were highly susceptible to fungal 
infection 56. 
 
TLRs are abundantly expressed on antigen presenting cells such as dendritic cells and 
macrophages 49. The cytoplasmic portion of TLRs shows high similarity to that of the 
interleukin (IL)-1 receptor family, and is now called the Toll/IL-1 receptor (TIR) domain. 
Chapter I 
 
 
Ana Catarina Mota Correia 
14 
Despite this similarity, the extracellular portions of both types of receptors are structurally 
unrelated. The IL-1 receptors possess an Ig-like domain, whereas TLRs bear leucine-rich 
repeats (LRRs) in the extracellular domain  87. 
TLRs signal through two major pathways: the MyD88-dependent pathway and the TRIF 
(Toll/IL-1R domain-containing adaptor-inducing IFN-beta)-dependent pathway. The MyD88-
dependent pathway triggers the release of pro-inflammatory cytokines, such as TNF-alpha, 
IL-6, and IL-12p40. MyD88 recruits various molecules that include IRAK4 (IL-1R-associated 
kinase 4), IRAK1 and TRAF6 (TNFR-associated factor 6) which in turn activate the nuclear 
factor-κB (NF-κB) that induces pro-inflammatory cytokine genes. The TRIF-dependent 
pathway is unique to TLR3 and TLR4 and contributes to pro-inflammatory cytokine 
responses as well as to the induction of type I IFN responses, particularly IFN-beta. To 
achieve this, TRIF recruits TRAF3, TBK (TRAF family member-associated NF-κB activator 
binding kinase) and IKKepsilon (Iκ B kinase epsilon), that activate IRF3 (IFN-regulatory 
factor 3) (Figure 3) 9, 25, 86. 
 
Figure 3 – TLR signalling pathway 110 
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The Toll family of proteins seems to be conserved, since homologous proteins have been 
described not only in Drosophila but also in other organisms, including plants. Thirteen TLRs 
(TLR1 to TLR13) have been identified in humans and mice together, and equivalent forms of 
many of these have been found in other mammalian species. However, equivalents of certain 
TLR found in humans are not present in other mammals 31, 21, 86.  
Different TLRs exhibit specific responses. In fact, they have their own signalling molecules to 
manifest these specific responses and can be classified according to the types of PAMPs they 
are able to recognize (Figure 4) 87. For instance, TLR2, 4 and 6 recognize lipids. In addition, 
TLR4 together with its extracellular components, MD-2 and CD14, can also recognize 
lipopolysaccharide (LPS) from Gram-negative bacteria. TLR2, in turn, forms heterodimers 
with TLR1, TLR6 and CD36 to discriminate molecules such as peptidoglycan, lipopeptides 
and lipoproteins of Gram-positive bacteria, mycoplasma lipopeptides and fungal zymosan. 
TLR5 recognizes protein ligands such as bacterial flagellin. Human TLR10 is thought to 
heterodimerize with TLR2 and TLR1, but the target ligand remains unknown 5, 49, 95.  
 
Figure 4 – Ligands recognized by the TLR family 1 
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One of the best ways to understand the central role for TLR in inflammatory responses is 
through mice lacking specific TLR or signalling molecules. For instance, mice lacking TLR4 
are non responsive to LPS and, consequently, more susceptible to infection by Gram-negative 
bacteria such as Salmonella typhimurium, and mice deficient in TLR2 show a profoundly 
diminished response to Gram-positive organisms such as Staphylococcus aureus. In spite of 
these results, it is important to note that not all TLR deletions lead to severe infection 
phenotypes. This suggests that there may be a redundancy in recognition since probably all 
microorganisms are most likely to be recognized by multiple TLRs and not just one. In 
addition to being recognized by TLRs, microbes are also recognized by other innate 
recognition systems, as a way to prevent pathogens from easily subverting recognition and in 
consequence generating a controlled inflammatory response 92. 
 
1.1.3.4) The I329L gene of the ASFV 
ASFV is adapted to survive in vertebrate and invertebrate host cells. Both types of cells have 
defence mechanisms that are regulated by TLRs. In the porcine host, the virus mainly infects 
the macrophage, a key cell in innate immunity, as described earlier. For these reasons, the 
ASFV genome has been analysed using bioinformatic tools, and through this analysis the 
I329L gene was identified. 
ORF I329L is a putative transmembrane protein of the ASFV of unknown function, with an 
extracellular domain of 222 amminoacids, a central transmembrane region formed by 21 
residues, and 40% homology with the highly conserved 69 amminoacid intracellular C-
terminal domain of mammalian Toll like receptors (TLRs). The protein coded by this gene 
shows a variety of potential glycosylation sites (Glc NAc) in the following amminoacids: 32, 
39, 44, 76, 82, 101, 105, 219. These features suggest that I329L may be a candidate viral TLR 
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homologue. In fact, searches for similarities with other proteins in databases, in particular 
after alignment with TLR proteins, have shown a significant similarity between I329L and 
TLR3 from Drosophila melanogaster, specifically in a repetition site rich in leucine residues.  
 
Figure 5 – Hypothetical model for I329L based of bioinformatic tools. TLRs 
are extremely rich in leucine residues as well as the conserved region of this 
protein. The extracellular portion of the molecule is formed by LRR repeats, an 
important motif for the interaction of these protein wit other molecules. Even 
though it is not clear whether I329L has a TIR domain, it resembles TRIFs in its 
cytoplasmatic domain. This suggests that this gene may modulate signalling 
through its interaction with TRIF. (Unpublished model developed by Vívian 
Oliveiraat the IGC) 
 
The demonstration of interference of this gene with the activation of NF-κB, through a TLR-
NF-κB reporter gene assay, has been performed in our lab by Vívian Oliveira (unpublished 
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data) and constitutes the stimulus for my work. The reporter gene assay consists on 
transfecting HEK-293T cells with three plasmids: one, containing a NF-κB-driven luciferase 
reporter, a second containing a CD4 extra-cellular domain co-ligated upstream of a set of TLR 
intracellular domains comprising TLR-1-6. As CD4 domains spontaneously dimerize when 
incorporated into the 293T cell membrane, the TLR intracellular domains are automatically 
brought into apposition. Therefore, there is constitutive signalling from the dimerized TLRs, 
and the resulting activation of NF-κB is detected by synthesis of luciferase. The effect of the 
co-transfection of the candidate gene cloned into the third plasmid provides an assay for 
interference of the viral protein with the TLR signalling pathway. Empty pcDNA3 serves as 
the negative control. It was observed that I329L inhibits NF-κB activation stimulated by 
multiple TLRs. This is of great importance since the NF-κB family of eukaryotic transcription 
factors is expressed in virtually all cell types and is involved in the regulation of expression of 
various genes important in immune response, inflammation and apoptosis, namely cytokines 
and its receptors, chemokines, growth factors and cell adhesion molecules 10, 11. Later 
unpublished experiments by Vívian Oliveira showed that stimulating cells with the TLR3 
ligand, polyinosinic-polycytidylic acid (poly(I:C)), a double stranded RNA analog, confirmed 
that I329L inhibited the TLR signaling transduction pathway. 
These results strongly suggest that I329L is a host modification gene and thus a suitable 
candidate for the construction of a mutant deletion virus vaccine. Work towards such a 
vaccine and a deeper understanding of the role of I329L in host-pathogen interaction 
constitutes the objective of this project. 
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1.2) OBJECTIVE 
This project is focused on exploring the function and utility of a host modification gene from 
the African Swine Fever Virus (I329L gene) manipulating toll receptor like (TLR) signalling. 
The goals of this project were to (1) determine whether I329L is an essential gene, (2) gain 
insights into function of the gene in the pig macrophage cell, and (3) assess of the impact of 
I329L in vivo by constructing a transgenic mouse selectively expressing I329L in 
macrophages. Such a transgenic mouse would be a model to understand how interference with 
TLR signalling might manipulate macrophage function in health and disease. 
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2) I329L IS A NON ESSENTIAL GENE OF THE ASFV 
 
2.1) INTRODUCTION 
One of the possible approaches to produce an attenuated ASFV is through the deletion of 
genes known to be involved in evasion of the host immune system. As described earlier in 
this thesis, the gene I329L is a candidate for the construction of a mutant deletion virus 
vaccine. In order to test this possibility, it is first necessary to demonstrate that this gene is 
non-essential for the virus growth and replication in vitro. If the gene was essential to the 
virus, then its deletion would not yield a viable virus. 
There are two possible approaches to test if this gene is essential to ASFV: 1) the knockdown 
of I329L through siRNA technology and 2) the construction of an I329L mutant deletion 
virus. 
 
2.1.1) Inhibition of expression of I329L through siRNA technology 
RNA interference (RNAi) is the process of mRNA degradation that is induced by double-
stranded RNA (dsRNA) in a sequence specific manner. This process has been observed in all 
eukaryotes, from yeast to mammals. The RNAi pathway is thought to be an ancient 
mechanism for protecting the host and its genome against viruses that use dsRNA in their life 
cycles. This process plays a role not only in RNA and dsRNA stability/degradation but also in 
the regulation of translation, transcription, chromatin structure, and genome integrity. In the 
RNAi pathway, the dsRNA is processed to short interfering RNA (siRNA) which consists in 
21-25 bp dsRNA with dinucleotide 3’ overhangs. Specifically, the guide strand of the siRNA 
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is assembled into an RNA-induced silencing complex (RISC) that cleaves the target mRNA 
79, 84. 
Due to its efficiency in specifically silencing the expression of any gene for which a sequence 
is available, it has been widely used and has become the cornerstone of many research 
projects. 
The production of infectious virus by appropriately siRNA transfected cells will prove that 
I329L is a non-essential gene and thus a candidate for generation of an attenuated I329L-
deleted ASFV vaccine. 
Conventional transfection was used for transferring siRNA to Vero cells for gene silencing. 
The conditions for I329L specific siRNA delivery were optimized to avoid cytotoxicity. Two 
RNA regions were selected and the corresponding siRNA oligonucleotides were purchased. 
At first, these were tested separately, but later on both were combined, as this was more 
effective than a single siRNA, to achieve knock down. 24 hours post-transfection of siRNA, 
Vero cells were then infected with Ba71v. To confirm gene silencing, RT-PCR to detect 
I329L mRNA was performed on transfected Vero cells collected 18 hours post-infection. As a 
control, amplification of another ASFV gene (A238L) was also performed on the same 
samples in order to confirm the specificity of the silencing. The A238L gene of the ASFV is 
an inhibitor of transcription that encodes a bifunctional protein that inhibits both NF-κB and 
NFAT activation 65, 66, 75, 76. We chose this gene as a control, since it is expressed throughout 
the cycle of the virus, including the time point that we were studying. A non-specific siRNA 
sequence from Dharmacon served as the negative control. Non-targeting, negative controls 
provide a baseline for measuring the effects of experimental siRNAs. Negative siRNA 
controls lack sequence complementarity to gene products and should have no effect in mRNA 
stability, mRNA expression, or protein expression. These controls are important for 
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distinguishing sequence-specific silencing from non-specific effects in the RNAi experiment. 
There are a variety of negative controls available, but we used a “scramble” control. This 
strategy consists in using a siRNA that has the same nucleotide composition, but not the same 
sequence, as the test siRNA. This is achieved in two ways: randomizing (also known as 
scrambling) the nucleotides in the siRNA or reversing the sequence of the siRNA. When their 
sequences fail to target a known gene or have a miRNA seed region match with a known 
gene, these siRNAs are appropriate as negative control siRNAs. 
 
2.1.2) Construction of the I329L mutant deletion virus 
The genome of ASFV can be manipulated through a process of homologous recombination 
between the virus genome and plasmid vectors transfected into the infected cell. Even though 
this kind of approach has been limited by the lack of suitable transfer vectors, García et al. 
described the construction of plasmid vectors with applications permitting the generation of 
recombinant viruses containing multiple deletions as well as viruses expressing foreign genes. 
In this work, the plasmid p72GUS10T (5.1 kb) was selected. This contains an ASFV chimeric 
gene formed by the fusion of the coding sequence of the gusA gene to the virus promoter 
p72.4 which was cloned into the polylinker region of plasmid pUC118 34. 
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2.2) METHODS AND MATERIALS 
2.2.1) Cell lines 
Vero cells (African green monkey epithelial cells) were cultured in Dulbecco's Modified 
Eagle's Medium (DMEM) supplemented with 10% Fetal Calf Serum, FCS, (heat inactivated), 
2mM L-Glutamine, 100 Units/mL Penicillin, 100 μg/mL Streptomycin, all purchased from 
Gibco, Invitrogen Corporation. 
Cells were routinely checked for mycoplasm contamination by performing a specific PCR. 
 
2.2.2) siRNA Transfection and Ba71v infection 
2.2.2.1) Treatment with siRNA oligos 
siRNA targets were used to knock down expression of I329L in Vero cell lines. siRNA target 
sequences were purchased from Dharmacon. We chose two target sequences to be transfected 
into Vero cells: target 1, 5’-CAACCTACCTATATTACAA-3’ and target 2, 5’-
TTATGCTCCTGTATATCAT-3’. These primers were kept at a 75 µM stock concentration. 
We first transfected each target separately but afterwards we had to combine the two in 
transfection in order to see an effect. 
 
3x105 cells/well were seeded on 6 well plates and left overnight. On the following day, cells 
were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s 
instructions and left overnight. On day 3, 24 hours post-transfection, cells were infected with 
Ba71v using a multiplicity of infection (MOI) of 5. Ba71v is a tissue culture adapted Spanish 
isolate of the ASFV that encodes 151 major ORFs 105. All procedures regarding the use of 
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Ba71v were carried out at the P3 laboratory facility of the Instituto Gulbenkian de Ciência 
(Oeiras, Portugal) according to the in-house security rules. 
To perform the siRNA experiment we used the appropriate controls and also tested the 
minimum quantity of siRNA needed to observe gene knockdown. It is important to use as 
little quantity of siRNA possible as too much siRNA transfected into the cells may lead to off-
target or cytotoxic effects. On the other hand, if too little siRNA is used, reduction of target-
gene expression may be undetectable. The experimental scheme was according to figure 6. 
Cells Ci SCR
200 nM
25 nM
100 nM 50 nM
12,5 nM 6,25 nM
A
B
 
Figure 6 – siRNA experimental design scheme. A) We used three controls: 
Vero cells only, Ba71v infected cells (Ci) and negative control scramble 
transfected and Ba71v infected Vero cells (SCR). B) Vero cells were transfected 
with different quantities of siRNA (200nM-6.25nM) as well as infected with 
Ba71v (MOI 5). 
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2.2.2.2) Demonstration of siRNA inhibition of I329L expression by RT-PCR 
Total RNA was extracted from siRNA transfected and Ba71v infected Vero cells, using Trizol 
Reagent (Sigma). Samples of RNA were digested with DNase I (Invitrogen) and cDNA 
synthesis was performed using MMLV-Reverse Transcriptase (Invitrogen) according to the 
manufacturer’s instructions. I329L expression in the cDNA was detected by PCR, using Taq 
DNA Polymerase, on a PTC-100 Peltier-Effect Cycling apparatus. Primer sequences were 
I329Lup, 5’-GCTACTTCTTCTTGAACATGA-3’ and I329Llow, 5’-GCTTAGGAAGTG 
GCTTAACAGG-3’ and PCR conditions were dNTPs 200 µM, primers 1 µM, MgCl2 2 mM, 
94ºC – 4’, 40X (94ºC – 1’, 50ºC – 1’, 72ºC – 2’), 72ºC – 10’. As a quantitative and qualitative 
control, tubulin was amplified using Taq DNA Polymerase with dNTPs 200 µM, primers 1 
µM, MgCl2 2 mM, 94ºC – 4’, 40X (94ºC – 1’, 55ºC – 1’, 72ºC – 2’), 72ºC – 10’. Tubulin 
primer sequences were the following: TubulinUp, 5’-GGTGGATCTAGAACCTGGG-3’ and 
TubulinLow, 5’-CCCAGTGAGTGGGTCAGC-3’. To control that only I329L expression was 
being targeted and not any other viral gene, the cDNA production for another ASFV gene, 
A238L, was also tested. A238L PCR was performed with Taq DNA Polymerase with dNTPs 
200 µM, primers 1 µM, MgCl2 2 mM, 94ºC – 3’, 40X (94ºC – 1’, 54ºC – 1’, 72ºC – 1’), 72ºC 
– 3’ and the primer sequences were A238Lup 5’-CTAGAATTCATGGAACACATGTTTCC 
A-3’ and A238Llow 5’-CTACTCGAGTTACTTTTCATACTTGTT-3’. 
 
2.2.2.3) Detection of intracellular and extracellular virus 
After knocking down the expression of I329L through siRNA we wanted to know if this gene 
was essential for the ASFV. With that purpose we 1) stained Ba71v infected Vero cells as 
well as siRNA transfected and Ba71v infected Vero cells, by immunofluorescence, using a 
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p73 specific monoclonal antibody; and 2) infected freshly plated Vero cells with the 
supernatants of each of the siRNA wells experiments, in order to count viral plaques. 
 
For immunofluorescence, sterilized glass coverslips were put in the wells as the cells were 
being seeded for the siRNA assays. As some of the cells adhered to the coverslip surface, we 
used them for a staining with an antibody against p73, a major capsid protein of ASFV. Cells 
were fixed with 4% paraformaldehyde (PFA) in PBS for 20 minutes at room temperature 
(RT). Blocking was performed at RT for 30 minutes with PBS containing 0.05% Tween-20 
and 5% Normal Goat Serum (NGS). The cells were permealized using PBS containing 0.1% 
Triton X-100. The staining with the primary monoclonal antibody 4H3 specific for p73 was 
performed at RT for 1 hour in blocking solution with a previously titrated concentration of the 
antibody. The secondary staining was also performed at RT for 1 hour with a goat anti-mouse 
IgG Alexa 568 antibody, purchased from Molecular Probes. To stain the nucleus of the cells, 
they were incubated in a DAPI solution (20 ng/µl) for 2 minutes. All washes between 
stainings were performed at RT in PBS containing 0.05% Tween-20. 
 
Viruses were recovered from the supernatants of siRNA transfected and infected cells. These, 
were then titrated with the purpose of counting viral plaques, to determine if infectious 
progeny was being produced after knocking-down I329L. 
In order to titrate the supernatants we used freshly plated Vero cells and infected them with a 
series of dilutions of the supernatants from pure supernatant to 10-1, 10-2, 10-3, 10-4 and 10-5 
dilutions. DMEM medium with 0.5% agarose was added to the infected cells and left for five 
days. Afterwards, the cells were washed with PBS 1X and fixed with 4% PFA for 20 minutes 
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at RT. The cells were then stained with 0.1% toluidine blue for 30 minutes at RT and washed 
with tap water. After drying, the viral plaques were counted. 
 
2.2.3) Cloning of the mutant deletion virus construct 
In order to delete I329L from Ba71v the left and right flanking regions (~700 bp each) of the 
ASFV gene were cloned on either side of the p72.4 Gus 10T cassette. For instance, the 
amplification of the left flank of the gene was performed by inserting an EcoRI site at the 5’ 
end and a KpnI or SmaI site at the 3’end (in this case we used a KpnI site). These sites were 
cloned upstream of p72.4 Gus 10T. The right flank of the gene was also amplified by 
inserting a PstI site at the 5’end and a HindIII site at the 3’end, in order to clone it 
downstream of the p72.4 Gus 10T cassette. 
KpnI/SmaI PstI
p72.4 Gus 10T
~ 2 kbp
I329L LF I329L RF
EcoRI HindII
 
Figure 7 - Cloning strategy of I329L left (LF) and right flanks (RF) into 
p72.4 Gus 10T plasmid. 
 
The right and left flanks (RF and LF, respectively) were amplified by PCR using Pfu DNA 
Polymerase, on a PTC-100 Peltier-Effect Cycling apparatus. Primer sequences were 
I329LRFup, 5’- GCCTGCAGCCTGTATATACTATTAAAAATT -3’, I329LRFlow, 5’- 
GCAAGCTTACCCTGATGGAAGACTATGTAT-3’, I329LLFup, 5’- GCGAATTCCATAA 
CTAGATCGGTGGTAAT-3’, and I329LLFlow, 5’- GCGGTACCATGTGTGGTTTATTTT 
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AGTATG -3’. PCR conditions were dNTPs 200 µM, primers 1 µM, MgSO4 2 mM, 94ºC – 4’, 
30X (94ºC – 1’, 55ºC – 1’, 72ºC – 2’), 72ºC – 10’. These fragments were restriction digested 
and cloned into p72.4 Gus 10T according to the scheme in figure 7. 
After infection of Vero cells with Ba71v, followed by transfection of the I329LLF-Gus-
I329LRF, progeny virus will be harvested, and the recombinants will be identified and 
purified by isolating viruses/plaques expressing the Gus gene (blue on X-Gluc substrate). 
Through the use of this strategy the Gus gene can be stably inserted into the Ba71v genome, 
replacing the I329L gene through recombinant homology. 
The cells will then be infected with the mutant deletion virus to check that there is virus 
production and thus confirm that I329L is a non-essential gene. Even though the construct is 
already cloned and verified by sequencing, the remaining part in the construction of the 
deletion virus is ongoing work in our lab. 
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2.3) RESULTS 
2.3.1) Expression of I329L during Ba71v infection in Vero cells 
The ASFV ORF I329L has been described as a late expression gene 77. In order to know the 
exact time point of expression of I329L during virus infection, we infected Vero cells with 
Ba71v and recovered the cells at different time points of infection: 8h, 10h, 12h, 14h, 16h, 
18h and 20h and the expression of this I329L gene was determined by RT-PCR. As can be 
seen, I329L is indeed a late gene, its mRNA first being detected at 14h, 16h and 18h (Figure 
8). 
1      2     3     4     5     6      7     8
I329L
Tubulin
A
B
 
Figure 8 – Expression of I329L during Ba71v infection. A) RT-PCR for the 
I329L gene is negative for non infected cells (lane 1) as well as for time points 
8h, 10h and 12h after infection (lanes 2, 3 and 4). I329L was expressed at 14h, 
16h and 18h post infection (lanes 5, 6 and 7), but not at 20h post infection (lane 
8). B) PCR for tubulin, as a control of the quantity and quality of the cDNAs. 
 
After demonstrating transcription of I329L at 14h, 16h and 18h post infection, we decided to 
use the 18h time point for the next steps of the siRNA experiment. 
All the following procedures regarding siRNA described in this thesis were performed at this 
time point of infection. 
 
Chapter II 
 
 
Ana Catarina Mota Correia 
30 
 
2.3.2) Transfection of siRNA targets in Ba71v infected Vero cells 
We first decided to test the transfection of each siRNA target (1 and 2) separately in order to 
see if one target sequence was able to induce the knockdown of the gene. However, under 
these conditions, I329L expression was not suppressed (Figure 9A, 9B). On the other hand, 
when we combined both targets and transfected them into the cells, an inhibition of 
expression of I329L was observed with a concentration of siRNAs of 200 nM (Figure 9C). 
The inhibition was specific and the combined treatment with two siRNA probes did not 
inhibit transcription of A238L (Figure 9D). 
I329L
A238L
Tubulin
1     2      3    4  
I329L
I329L
A
1     2      3    4  
B
C
D
E
(Target 1)
(Target 2)
 
Figure 9 – Expression of I329L after transfection of siRNA targets and 
infection with Ba71v. A, B) Transfection of targets 1 and 2 respectively, non 
combined. RT-PCR for the I329L gene is negative for non transfected and non 
infected cells (lane 1), but positive for infected cells (lane 2) as well as for cells 
transfected with siRNA negative control Scramble (lane 3). Cells transfected with 
only one of the siRNA targets do not inhibit I329L expression (lane 4). C) RT-
PCR for the I329L gene is negative for non transfected and non infected cells 
(lane 1), and positive for infected cells (lane 2) as well as for infected cells 
transfected with siRNA negative control Scramble (lane 3). Lane 4 demonstrates 
that I329L expression was knocked down by transfection of a combination of 
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both siRNA targets at a final concentration of 200 nM. D) RT-PCR for the 
A238L gene (lanes 2, 3 and 4) not only demonstrates that the cells are infected, 
but also that the siRNA target sequences are specific for I329L and have no effect 
in the expression of other viral genes. E) Tubulin amplification served as a 
control for the quantity and quality of the cDNAs. 
 
2.3.3) siRNA titration in Ba71v infected Vero cells 
It is important to use the minimum quantity of siRNA as possible, as too high concentrations 
of siRNA transfected into the cells may lead to off-target or cytotoxic effects. On the other 
hand, if too little siRNA is used, the reduction of target-gene expression may be insufficient. 
Thus the amounts of siRNA tested in the transfection step were titrated (200 nM-6.25 nM). 
Effective knockdown was observed at oligonucleotide concentrations of 100 nM or 200 nM 
(lanes 5 and 4 respectively, Figure 10A). Lower quantities did not result in the inhibition of 
I329L expression (lanes 6-9, Figure 10A). Once again, there was no impact on transcription 
of the positive control, A238L. 
I329L
A238L
Tubulin
1     2      3     4      5      6      7     8     9
A
B
C
 
Figure 10 – Titration of the quantity of siRNA targets in infected Vero cells. 
A) RT-PCR for the I329L gene is negative for non transfected and non infected 
cells (lane 1), and positive for infected cells (lane 2), as well as for cells 
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transfected with siRNA negative control Scramble (lane 3). Lanes 4-9 correspond 
to 200 nM, 100 nM, 50 nM, 25 nM, 12.5 nM and 6.25 nM of siRNA target 
transfection titration respectively. I329L expression is knocked down at 200 nM 
and 100 nM concentrations of siRNA targets (lanes 4 and 5). Lower 
concentrations of siRNA target were unable to knockdown expression of I329L 
(Lanes 6-9). B) RT-PCR for the A238L gene not only demonstrates that the cells 
are infected, but also that the siRNA target sequences are specific for I329L and 
have no effect in the expression of other viral genes. C) PCR for tubulin, as a 
control of the quantity and quality of the cDNAs. 
 
 
2.3.4) Analysis of virus production from infected Vero cells transfected with 
I329L siRNA targets 
After confirming the specific knock-down of I329L through siRNA technology, we next 
investigated 1) the impact of knockdown of I329L on virus production and 2) the production 
of infectious virus by cells by cells with synthesis of I329L knocked down. 
In order to achieve these objectives, we 1) stained the cells with an antibody against p73, a 
major capsid protein, to check that the cells were being infected and 2) recovered the 
supernatants from the siRNA transfected and for infection of Vero cells followed by counting 
the number of viral plaques. 
 
2.3.4.1) Staining of p73, the major capsid protein of ASF virus 
The major structural protein of ASFV is a capsid protein, p73. This protein is thought to 
associate with the membranes that form the envelope of the virus 23. Cobbold et al. generated 
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a mouse monoclonal antibody 4H3 to determine the onset of expression of p73 and the time 
course of packaging of capsid proteins into virions. 
We used this antibody followed by a Goat anti-mouse IgG Alexa 568 secondary antibody in 
cells infected with the culture supernatants from the control and I329L specific knocked down 
Ba71v virus infected Vero cells. 
 
As can be seen, there was no difference in the expression of p73 with or without siRNA 
knockdown of the I329L gene at all the concentrations of siRNA (200nM-6.25nM) tested. 
Only two of the images of the staining are presented in this thesis, one with just infected cells 
and one with both siRNA transfected (200nM) and infected cells (Figure 11). 
A B
 
Figure 11 – Staining of Vero cells with 4H3 monoclonal antibody. p73 can be 
observed in red and DAPI (blue) stains the nucleus. The staining was identical 
both in A) Ba71v infected cells and in B) siRNA transfected and Ba71v infected 
Vero cells (Magnification 40X). 
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2.3.4.2) Analysis of viable virus production from siRNA recovered supernatants 
After confirming the specific knockdown of I329L through siRNA technology we used the 
supernatants of the Ba71v virus infected cells with and without siRNA mediated knockdown 
of I329L. 
By comparing the number of viral plaques of Ba71v infected cells and Ba71v infected and 
transfected cells (with siRNA in the concentrations range defined) we could conclude that 
there was no impact in the production of infectious virus. Thus knocking-down I329L did not 
affect the production of infectious ASFV virus, and therefore I329L is truly a non-essential 
gene. 
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Figure 12 – Counting of viral plaques after siRNA supernatant titration. We 
observed no significant difference in the number of viral plaques by comparing 
the number of plaques counted both after infection with the supernatant of Ba71v 
infected cells (non siRNA transfected, sample 2) and the supernatant of Ba71v 
infected and scramble siRNA transfected cells (sample 3), with the number of 
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plaques counted after infection with the supernatants of both I329L siRNA 
transfected and Ba71v infected cells (samples 4-9).  
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2.4) DISCUSSION 
RNAi is an effective method of gene silencing, and is a very important tool in the study of 
genetics, molecular biology and physiology. It has been yielding considerable insights into the 
innate and adaptive immune systems, namely into the mechanisms that regulate the 
development, activation and function of cells that mediate immunity. Even though this 
technique may in the future be tested for clinical purposes, its limitations such as inefficient 
delivery in vivo, incomplete silencing of target genes, non-specific immune responses and off-
target effects, must first be overcome. Nevertheless, it seems to be a powerful and promising 
tool applicable to vaccination and immunotherapy 61. 
The I329L ORF is a host modification gene of the ASFV, as suggested by previous results in 
our lab, and therefore a suitable candidate for the construction of a mutant deletion virus 
vaccine. We decided to take two approaches to investigate whether this gene was essential to 
the virus or not. 
In the first one, we used siRNA oligos in order to specifically knockdown the expression of 
I329L in Ba71v Vero infected cells. The I329L gene, already described as a late expression 
gene 77, was knocked down at the time of its expression at 18 hours post infection. Upon 
siRNA oligo transfection we were able to see an inhibition of expression when using a 
combination of two oligos at 100 and 200 nM. Furthermore, supernatants recovered from 
cells infected with virus, but with expression of I329L knocked down, contained similar 
numbers of effective virus as control non-knocked down infected cultures. To further confirm 
that the cells had been infected, we performed immunofluorescence using a monoclonal 
antibody against p73, a major capsid protein of the virus. Once again, we observed no 
difference between the staining of control infected cells and cells that were both infected and 
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treated with siRNA to knockdown the expression of I329L. In addition, these results show 
that p73 expression is not affected by the knocking down of I329L and, in consequence, virus 
envelope formation is not altered. 
The fact that the knockdown of expression of this gene does not affect assembly and 
production of infectious virus, not only shows RNA technology can be used to inhibit I329L 
synthesis in ASFV infected cells, but also constitutes the key finding of this study, namely 
that I329L is a non essential gene of the ASFV. Thus, the data presented in this chapter, 
together with the fact that I329L inhibits TLR3, makes this host manipulation gene a possible 
candidate to delete for the production of a viral attenuated vaccine. 
Another approach to show that this gene was not essential to the virus was through the 
construction of an I329L mutant deletion virus. To this end, the necessary recombinant 
transfer plasmid for construction of the I329L deletion mutant has been constructed and the 
remaining work towards construction of the I329L deletion mutant is ongoing in our lab. 
Whether such a mutant will indeed prove to be a vaccine candidate will depend on its 
pathogenicity in the pig. If still pathogenic, one approach to achieve the vaccine would be to 
sequentially delete other genes known to be involved in evasion of the host immune system, 
such as I329L, or genes required for virus virulence or for efficient replication in the tick 
vector. The deletion of these immune evasion genes might change the balance in favour of the 
virus towards an effective host immune response and thus an increased chance of developing 
an effective protective immune response in vaccinated animals. This strategy has been shown 
to be efficient in Herpes simplex virus, where the blocking of virus immune evasion proteins 
improved the potency of the vaccine 48. 
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3) FAILURE TO DETECT AN IMPACT OF I329L EXPRESSION IN 
SUPEROXIDE PRODUCTION STIMULATED BY LPS AND DSRNA (POLY 
I:C) IN IPAM CELLS 
 
3.1) INTRODUCTION 
Macrophages play an important role in the control of inflammation as well as in the regulation 
of immune response and indeed upon viral infection, macrophages can contribute to 
immunopathology in the host. Because of this, some viruses have evolved genes which are 
cytokine analogues, function as cytokine and chemokine receptors, or provide mechanisms 
that inhibit cytokine function 2, 64, 100. 
Inflammation an important early response to infection. For example, multiple inflammatory 
cells such as eosinophils, neutrophils and macrophages have the ability to generate reactive 
oxygen species (ROS), which not only damage the pathogen but may also lead to disease 70. 
In relation to macrophages, it is important to distinguish between the different cell types of 
monocytic origin, since there may be differences in terms of antioxidant and redox properties. 
For instance, alveolar macrophages, located between air and lung tissue are directly exposed 
to high oxygen levels and various pollutants, and therefore have different characteristics from 
peritoneal macrophages in terms of their ability to release TNF-α, IL-6, NO or O2- 32. In 
addition, the effects of oxidants on redox signalling appear to be cell-specific and stimulus-
dependent 32. A better understanding of the mechanisms through which ROS/RNS (Reactive 
oxygen and nitrogen species respectively) may affect macrophage response could have 
valuable implications for the development of anti-inflammatory therapeutics since these cells 
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are involved in propagating inflammation, through the secretion of pro-inflammatory 
molecules, as well as in the resolution of the inflammatory response through phagocytosis of 
apoptotic and necrotic cells 32. 
As previously described in this thesis, ASFV is a DNA virus that infects macrophages of 
domestic swine. Although the basis of the biological changes caused by this virus are not fully 
understood, cytokine expression could cause inflammation as well as induce changes in 
immune function at sites of infection. Also, once infected, macrophages may respond 
differently to cytokines. Studies have been carried out to test the ability of infected 
macrophages to produce different cytokines. This was evaluated through the production of 
superoxide, in response to interferon-γ (IFN-γ) and lipopolysaccharide (LPS) stimulation 100. 
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3.2) METHODS AND MATERIALS 
3.2.1) Cell lines 
IPAM cells (Immature porcine alveolar macrophages), IPAM cells infected with empty 
lentiviruses and IPAM cells infected with I329L recombinant lentiviruses, previously 
available in the lab and supplied by Vívian Oliveira, were cultured in RPMI 1640 with 
glutamine medium supplemented with 10% Fetal Calf Serum (FCS, heat inactivated), 100 
Units/mL Penicillin, 100 μg/mL Streptomycin, and 1 mM sodium pyruvate all purchased 
from Gibco, Invitrogen Corporation. 
Cells were routinely checked for contamination with mycoplasm by performing a specific 
PCR. 
 
3.2.2) I329L expression in I329L lentivirus-transduced IPAM cells 
Lentivirus-based vectors are under development in gene therapy research since, unlike 
oncoretrovirus vectors, these allow the delivery of genes to a variety of target cells. Human 
immunodeficiency virus (HIV)-based vectors have been used both in vitro and in vivo, 
through the removal of some accessory genes that minimize the risk from them. However 
there is still some concern if they are to be used in HIV-infected patients. As an alternative, 
lentivirus-based vectors, derived from non-primate lentiviruses not know to be pathogenic or 
infectious for humans, have been developed so that they have the ability to transduce non-
dividing cells. Feline immunodeficiency virus (FIV) and equine infectious anaemia virus 
(EIAV) are two examples of lentivirus-based vectors that have a minimal sequence homology 
to HIV and weak transcriptional activity in human cells 44. 
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A scheme of the cloning vector used to produce lentivirus with our gene of study is shown on 
figure 13. 
LTR
RRE
SFFV
promoter
cPPT
Emerald
IRES
WPREΨ
 
Figure 13 – Scheme of the cloning vector SIN-BX-IR/EMW. This vector has a 
5’ long terminal repeat (LTR), but not a 3’, which makes it non-infectious. It also 
has a rev-responsive element (RRE), a central polypurine tract (cPPT), a spleen 
focus forming virus (SFFV) promoter, an internal ribosome entry site (IRES) 
sequence, an emerald sequence (that is similar to eGFP, but with a 4 point 
mutation that makes it much more brighter) and a Woodchuck hepatitis virus 
post-transcriptional regulation element (WPRE) sequence. To develop the 
lentivirus carrying our gene of interest, an HA tag was also cloned upstream the 
viral gene. The final construct consisted on HA-I329L being cloned upstream the 
IRES sequence and downstream the SFFV promoter. 
 
In order to check if I329L was being expressed in the I329L lentivirus-transduced IPAM cell 
line, we used two approaches, 1) detection of I329L mRNA expression by RT-PCR and 2) 
detection of I329L through immunofluorescence using an antibody against the co-expressed 
HA tag. 
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3.2.2.1) Detection of I329L expression by RT-PCR 
Total RNA was extracted from I329L lentivirus-transduced IPAM cells and also from IPAM 
cells and empty lentivirus-transduced IPAM cells (as controls), using Trizol Reagent (Sigma). 
Samples of RNA were digested with DNase I (Invitrogen) and cDNA synthesis was 
performed using MMLV-Reverse Transcriptase (Invitrogen) according to the manufacturer’s 
instructions. I329L expression in the cDNA was detected by PCR, using Taq DNA 
Polymerase, on a PTC-100 Peltier-Effect Cycling apparatus. Primer sequences were I329Lup, 
5’-GCTACTTCTTCTTGAACATGA-3’ and I329Llow, 5’-GCTTAGGAAGTGGCTTAAC 
AGG-3’ and PCR conditions were dNTPs 200 µM, primers 1 µM, MgCl2 2 mM, 94ºC – 4’, 
40X (94ºC – 1’, 50ºC – 1’, 72ºC – 2’), 72ºC – 10’. As a quantitative and qualitative control, 
tubulin was amplified using Taq DNA Polymerase with dNTPs 200 µM, primers 1 µM, 
MgCl2 2 mM, 94ºC – 4’, 40X (94ºC – 1’, 55ºC – 1’, 72ºC – 2’), 72ºC – 10’. Tubulin primer 
sequences were the following: TubulinUp, 5’-GGTGGATCTAGAACCTGGG-3’ and 
TubulinLow, 5’-CCCAGTGAGTGGGTCAGC-3’. 
 
3.2.2.2) Detection of I329L through immunofluorescence 
I329L lentivirus-transduced IPAM cells, already constructed by Vívian Oliveira were tested 
by immunofluorescence for I329L expression, using an antibody to the coexpressed Influenza 
haemaglutinin peptide (HA) tag, cloned upstream the viral gene. 
For immunofluorescence, sterilized glass coverslips were put in the wells containing the 
IPAM cells until they became adherent. Afterwards, cells were fixed with 4% 
paraformaldehyde (PFA) for 20 minutes at room temperature (RT). Blocking was performed 
at RT for 30 minutes with PBS containing 0.05% Tween-20 and 3% Bovine Serum Albumine 
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(BSA). The cells were permealized by treatment with PBS containing 0.1% Triton X-100 for 
20 minutes. The staining with the primary antibody rat anti-HA was performed at RT for 1 
hour in blocking solution with a previously titrated concentration of the antibody. The 
secondary staining was also performed at RT for 1 hour with a goat anti-rat FITC. Rat anti-
HA (high affinity) was purchased from Roche and goat anti-Rat-FITC (adsorbed against 
mouse Ig) was purchased from SouthernBiotech. 
To stain the nucleus of the cells, coverslips were incubated in a DAPI solution (20 ng/µl) for 2 
minutes. All washes between stainings were performed at RT in PBS containing 0.05% 
Tween-20. 
 
3.2.3) Assays of macrophage function 
Whittall and Parkhouse described a protocol in pigs in which alveolar and peritoneal 
macrophages were obtained by lavage of lungs and lavage of peritoneum respectively. 
Afterwards, they performed assays of macrophage function through the evaluation of 
responses to IFN-γ (interferon gamma) and LPS (lipopolysaccharide) by measuring the ability 
of macrophages to produce superoxide after stimulation with phorbol myristate (PMA), using 
nitroblue tetrazolium (NBT) for detection 100. 
The NBT test has been widely used to measure superoxide release by macrophages during an 
oxidative burst. This method allows the measurement of reduced NBT formazan, through its 
solubilization 78. 
We followed an adaptation of the protocol described, using IPAM cells. After checking the 
ability of LPS to activate these cells, we repeated the protocol on empty lentivirus-transduced 
IPAM cells and on I329L lentivirus-transduced IPAM cells. 
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3.2.3.1) Measurement of nitric oxide 
1x105 IPAM cells/well were plated on a 96 well plate and left to adhere overnight. On the 
following day a series of LPS dilutions were prepared (10 000 ng/mL, 1000 ng/mL, 100 
ng/mL, 10 ng/mL and 1 ng/mL), added to the plates and incubated for 48 hours at 37ºC. Then, 
the medium was removed and replaced with RPMI medium with the same supplements 
described above, but without phenol red, and containing 1 mg/mL NBT, purchased from 
Sigma. PMA, also purchased from Sigma, was also added at a concentration of 1 μg/mL, in 
order to stimulate the cells. Plates were incubated at 37ºC for 30 minutes. Afterwards, the 
medium was removed and IPAM cells were fixed with 70% methanol for 20 minutes at RT. 
Finally, formazan dye was solubilized by adding 120 μl of 2M potassium hydroxide and 180 
μl of dimethyl sulphoxide. The plate was read at 595 nm on a Microplate Manager 4.0 Bio-
Rad apparatus. 
 
3.2.3.2) Measurement of nitric oxide  in control and I329L -transduced IPAM cells 
After checking the background levels in IPAM cells, we then proceeded to repeat the assay on 
I329L lentivirus-transduced IPAM cells and in empty lentivirus-transduced IPAM cells as the 
negative control. Based on the results we obtained on IPAM cells, we decided to use only 
LPS and poly(I:C) to stimulate the cells, and not PMA. 
1x105 IPAM cells/well were plated on a 96 well plate and left to adhere overnight. On the 
following day a series of LPS dilutions were prepared (10 000 ng/mL, 1000 ng/ mL, 100 ng/ 
mL, 10 ng/ mL and 1 ng/ mL), added to the plates and incubated for 48 hours at 37ºC. Then, 
the medium was removed and replaced with RPMI medium with the same supplements 
described above, but without phenol red, and containing 1 mg/mL NBT, purchased from 
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Sigma, and the plates were incubated at 37ºC for 30 minutes. Afterwards, the medium was 
removed and the cells were fixed with 70% methanol for 20 minutes at RT. Finally, formazan 
dye was solubilized by adding 120 μl of 2M potassium hydroxide and 180 μl dimethyl 
sulphoxide. The plate was read at 595 nm on a Microplate Manager 4.0 Bio-Rad apparatus. 
This assay was also done using a polyinosinic-polycytidylic acid (poly(I:C)) stimulus instead 
of an LPS one. The concentrations tested for poly(I:C) were 125 μg/ml, 25 μg/ml, 5 μg/ml 
and 1 μg/ml. 
 
3.2.3.3) Analysis of porcine cytokine gene expression through RT-PCR 
To assess cytokine expression upon poly(I:C) stimulation of IPAM cells, empty lentivirus-
transduced cells and I329L lentivirus-transduced cells, were plated in a 6-well plate, 6x105 
cells/well. On the following day they were stimulated with 5 μg/ml poly(I:C) and left for 48h. 
Then, total RNA was collected from stimulated and non-stimulated cells (controls), using 
Trizol Reagent (Sigma). RNA samples were digested with DNase I (Invitrogen) and cDNA 
synthesis was performed using MMLV-Reverse Transcriptase (Invitrogen) according to the 
manufacturer’s instructions. IFN-α, IFN-β, IFN-γ and control β-actin expression in the cDNA 
was detected by PCR, using Taq DNA Polymerase, on a PTC-100 Peltier-Effect Cycling 
apparatus. Primer sequences were IFN-αUp, 5’-GGCTCTGGTGCATGAGATGC-3’ and 
IFN-αLow, 5’-CAGCCAGGATGGAGTCCTCC-3’ and PCR conditions were dNTPs 200 
µM, primers 1 µM, MgCl2 2 mM, 95ºC – 2’, 40X (95ºC – 30’’, 50ºC – 10’’, 72ºC – 30’’), 
72ºC – 10’  20. Primer sequences for IFN-βUp, 5’-GGCCATGGCTAACAAGTGCATCC-3’ 
and IFN-βLow, 5’-CCGGTCAGTTCCGGAGGTAATC-3’ and PCR conditions were dNTPs 
200 µM, primers 1 µM, MgCl2 2 mM, 94ºC – 4’, 40X (94ºC – 1’, 50ºC – 1’, 72ºC – 2’), 72ºC 
– 10’ 83. Primer sequences for IFN-γUp, 5’-GTTTTTCTGGCTCTTACTGC-3’ and IFN-
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γLow, 5’-CTTCCGCTTTCTTAGGTTAG -3’ and PCR conditions were dNTPs 200 µM, 
primers 1 µM, MgCl2 1.5 mM, 94ºC – 3’, 33X (94ºC – 45’’, 54ºC – 45’’, 72ºC – 45’’), 72ºC – 
10’ 88. As a quantitative and qualitative control, β-actin was amplified using Taq DNA 
Polymerase with dNTPs 200 µM, primers 1 µM, MgCl2 2 mM, 94ºC – 3’, 28X (94ºC – 45’’, 
54ºC – 45’’, 72ºC – 45’’), 72ºC – 10’. β-actin primer sequences were the following: β-
actinUp, 5’-GGACTTCGAGCAGGAGATGG-3’ and β-actinLow, 5’-
GCACCGTGTTGGCGTAGAGG-3’ 30. 
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3.3) RESULTS 
3.3.1) I329L expression in I329L lentivirus-transduced IPAM cells 
The expression of I329L on I329L lentivirus-transduced IPAM cells was confirmed at the 
RNA level by RT-PCR, and at the protein level by immunofluorescence using an antibody 
specific for the HA immunotag. 
 
3.3.1.1) Detection of I329L expression by RT-PCR 
We collected RNA and consequently synthesized cDNA from IPAM cells, empty lentivirus-
transduced IPAM cells, and I329L lentivirus-transduced IPAM cells. Then, we checked for 
expression of I329L, by RT-PCR. We observed that only I329L lentivirus-transduced IPAM 
cells cDNA expressed I329L, as expected. Tubulin amplification was used as a control for the 
quality and quantity of the RNA (Figure 14B, bottom panel). 
I329L
Tubulin
1   2      3
A
B
 
Figure 14 – Expression of I329L cDNA in I329L lentivirus-transduced IPAM 
cells. A) RT-PCR for the I329L gene is negative for IPAM cells (lane 1) as well 
as for empty lentivirus-transduced IPAM cells (lane 2). I329L expression was 
detected in I329L lentivirus-transduced IPAM cells. B) PCR for tubulin, as a 
control of the quantity and quality of the cDNAs. 
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3.3.1.2) Detection of I329L expression by immunofluorescence 
An immunofluorescence was performed against the HA immunotag. We observed I329L 
expression on I329L lentivirus-transduced IPAM cells (Figure 15C), but not in control 
untreated IPAM cells (Figure 15A) or empty lentivirus-transduced IPAM cells (Figure 15B). 
Interestingly, the staining of I329L was confined to the perinuclear area of the cells indicating 
its selective localization in the Golgi apparatus. 
A B C
 
Figure 15 – Staining of I329L lentivirus-transduced IPAM cells, with and anti-
HA antibody. A) IPAM cells showing a DAPI (blue) stained nucleus B) empty 
lentivirus-transduced IPAM cells C) I329L lentivirus-transduced IPAM cells, 
showing anti-HA specific staining in the perinuclear area (red). (Magnification 
60X) 
 
3.3.2) Superoxide production measurement on IPAM cells after LPS and PMA 
stimulation 
Having demonstrated expression of the viral protein in the recombinant retrovirus transduced 
IPAM cells, the next step was to determine the impact of the virus protein. First, we 
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confirmed that IPAM cells are respondive to LPS stimulation, using a series of dilutions of 
LPS and PMA, and measured superoxide production using NBT (Table 1), as described by 
Whittall and Parkhouse 100. As negative controls, we also measured the responses of IPAM 
cells alone and IPAM cells+NBT. 
 
Table 1 – Absorbance readings on LPS and PMA triggered IPAM cells 
 [LPS] Absorbance 
IPAM Cells - 0.192 
IPAM cells + NBT - 0.181 
IPAM cells + LPS + 
NBT 
1 ng/ mL 
10 ng/ mL 
100 ng/ mL 
1000 ng/ mL 
10 000 ng/ mL 
0.524 
0.559 
0.394 
0.441 
0.420 
IPAM cells + LPS + 
PMA + NBT 
1 ng/ mL 
10 ng/ mL 
100 ng/ mL 
1000 ng/ mL 
10 000 ng/ mL 
0.438 
0.581 
0.490 
0.534 
0.459 
 
We observed that IPAM cells can be triggered through stimulation with LPS alone as well as 
with a combination of both LPS and PMA. In fact, the addition of PMA did not augment 
superoxide production values, compared with IPAM cells that were only stimulated with LPS. 
In the negative controls, superoxide production values were virtually the same in both 
controls of IPAM cells (0.192) alone and IPAM cells with NBT (0.181), suggesting that NBT 
does not stimulate macrophages. 
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Next, we repeated this assay on control and I329L recombinant lentivirus-transduced IPAM 
cells, using only LPS as the stimulus. 
 
 
3.3.3) Superoxide production measurement on empty lentivirus-transduced 
IPAM cells and I329L lentivirus-transduced IPAM cells after LPS 
stimulation 
A series of dilutions of LPS were used to stimulate untreated IPAM cells, empty lentivirus-
transduced IPAM cells and recombinant I329L lentivirus-transduced IPAM cells. The assay 
was performed this assay in triplicates with unstimulated IPAM cells as the negative control. 
We observed a stimulation of superoxide production by IPAM cells upon stimulation with 
LPS, as mentioned above (4.3.2). The differences in superoxide production are not significant 
in the various LPS concentrations. Regarding superoxide production in empty lentivirus-
transduced IPAM cells and I329L lentivirus-transduced IPAM cells upon stimulation with 
LPS, we observed no difference, when comparing with the results on IPAM cells. The 
stimulation with LPS was not titratable, similar responses being observed with all 
concentrations of LPS tested (Figure 16). 
 
The most important result, disappointing however, was the failure of ASFV gene I329L to 
modify the response of IPAM cells to LPS. 
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Figure 16 – Superoxide production of IPAM cells, empty lentivirus-
transduced IPAM cells and I329L lentivirus-transduced IPAM cells, upon 
LPS stimulation. The graph shows that superoxide production is higher, once 
IPAM cells are stimulated with LPS, when compared with non stimulated cells 
(blue bars). It can also be observed that there is no significant difference between 
IPAM cells, empty lentivirus-transduced IPAM cells (pink bars) and I329L 
lentivirus-transduced IPAM cells (yellow bars) in terms of superoxide production, 
even with a wide range of stimulation by LPS. 
 
3.3.4) Superoxide production measurement on empty lentivirus-transduced 
IPAM cells and I329L lentivirus-transduced IPAM cells after poly(I:C) 
stimulation 
Previous results regarding the I329L gene have shown that this gene inhibits TLR3 signaling. 
We have used LPS as a stimulus, in order to repeat the experiment described by Whittall and 
Parkhouse. However, LPS is a ligand to TLR4. In order to mimic the recognition of a dsRNA 
by TLR3, we decided to use a different stimulus, with poly(I:C). 
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We tested a series of dilutions of poly(I:C), 125 μg/mL, 25 μg/mL, 5 μg/mL and 1 μg/mL, to 
trigger 3 cell lines: on IPAM cells, empty lentivirus-transduced IPAM cells and I329L 
lentivirus-transduced IPAM cells. We performed this assay in triplicates and used IPAM cells 
without poly(I:C) stimulus, as a control. 
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Figure 17 – Superoxide production of IPAM cells, empty lentivirus-transduced 
IPAM cells and I329L lentivirus-transduced IPAM cells, upon poly(I:C) 
stimulation. The graph shows that superoxide production is higher, once IPAM 
cells are stimulated with poly(I:C), when compared with non stimulated cells (blue 
bars). When cells were stimulated with 125 μg/mL and 25 μg/mL of poly(I:C), no 
difference was observed, in terms of superoxide production, between the three cell 
lines. This suggests that these concentrations may be toxic to the cells. Once the 
cells were stimulated with poly(I:C) at concentrations of 5 μg/mL and 1 μg/mL, we 
were able to observe a slight augment in superoxide production in I329L lentivirus-
transduced IPAM cells (yellow bars). However, this increase is not statistically 
significant because, even though there is a difference between stimulated I329L 
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lentivirus-transduced IPAM cells and stimulated IPAM cells, this difference is 
lower in relation to empty lentivirus-transduced IPAM cells (pink bars). 
 
3.3.5) Detection of cytokine expression by RT-PCR 
According to previous luciferase assay results in our lab, I329L inhibits IFN-β. 
In order to see if the cytokine levels were altered in this type of assay, we decided to assess 
cytokine expression in IPAM, empty lentivirus-transduced IPAM cells and I329L lentivirus-
transduced IPAM cells after these were stimulated with poly(I:C). IFN-α, IFN-β and IFN-γ 
expression was detected by RT-PCR. As can be seen (Figure 18) there was no impact of 
I329L expression on the transcription of IFN α, β, and γ. Interestingly, the IPAM cells 
synthesized IFN-γ. 
β-actin
A
D
B
C IFN-γ
IFN-β
IFN-α
1     2      3     4       5     6  
Figure 18 – Expression of IFN-α, IFN-β and IFN-γ cDNA in IPAM cells, empty 
lentivirus-transduced IPAM cells, and I329L lentivirus-transduced IPAM cells, 
upon poly(I:C) stimulation. Lanes 1, 3 and 5 correspond to non stimulated cells, and 
lanes 2, 4 and 6 correspond to poly(I:C) stimulated cells. A) RT-PCR for the IFN-α is 
positive in all cells B) RT-PCR for the IFN-β is positive for all cell types C) RT-PCR 
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for the IFN-γ is positive in all cells D) PCR for β-actin, as a control of the quantity and 
quality of the cDNAs. 
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3.4) DISCUSSION 
Innate immune responses are crucial in the control of viral infection. Once viral proteins or 
nucleic acids are recognized by pattern recognition receptors (PRRs) of the Toll-like receptor 
family, a triggering of the downstream signalling cascades occur. This may lead both to cell 
activation and cytokine production 62. 
 
Studies regarding the responsiveness of ASFV infected macrophages to IFN-γ and LPS have 
been described by Whittall and Parkhouse. This method comprised the measurement of 
superoxide production through the NBT method. The NBT test has been widely used in 
several areas, as a measurement of oxidative burst, based on the observation that leukocytes 
from patients with chronic granulomatous disease lack the ability to give an oxidative burst 7. 
It has also been widely used in order to measure macrophage activation  69.  
Whittall and Parkhouse observed that the infected cells were less responsive to IFN-γ and LPS 
than the cells infected with UV-inactivated virus. 
Although it is not the same assay, we decided to test IPAM cells (swine macrophages) in 
relation to their ability to respond to a range of concentrations of LPS. Upon LPS stimulation, 
we observed that these cells showed signs similar to infection, which reflected that LPS could 
function as stimulus for these cells. 
Afterwards, instead of using infected cells, as described in the original protocol, we decided 
to test the same conditions in IPAM cells that had previously been transduced with lentivirus 
expressing our study gene, I329L (tagged with an HA immunotag). As an additional control, 
we also used IPAM cells transduced with the empty lentivirus (empty lentivirus-transduced 
IPAM cells). These cells lines were tested not only for RNA expression of the gene, by RT-
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PCR, but also for protein production, by immunofluorescence. This assay could provide us 
clues on how the expression of this gene could affect the way in which the cells are able to be 
stimulated by LPS, in terms of superoxide production. The results showed us that there was 
no significant difference between the three cell lines tested (IPAM, IPAM emerald and IPAM 
I329L), after stimulation with LPS. 
Previous studies in our lab, have shown that I329L may be inhibiting Toll-like signalling 
pathway through TLR3 (unpublished data by Vívian Oliveira). Different TLRs, recognize 
different molecules, exhibiting different responses accordingly. While LPS is recognized by 
TLR4, TLR3 recognizes dsRNA molecules. Considering the interaction of I329L with TLR3, 
and not TLR4, the expression of this gene might not be expected to alter the levels of 
superoxide production in comparison with the control cells. To test this possibility, we 
decided to use poly(I:C) as a stimulus instead of LPS, since this molecule had previously been 
described as being able to activate macrophages, as well as B lymphocytes and dendritic cells 
62. Also, these responses are dependent on the expression of both TLR3 and TRIF 62. 
Poly(I:C), a double stranded RNA analog, is recognized by TLR3, that in turn seems to be 
inhibited by I329L. Surprisingly, upon stimulation of I329L lentivirus-transduced cells with 
poly(I:C) (5 μg/ mL and 1 μg/ mL) we noted a slight augmentation, that did not happen with 
higher doses of poly(I:C) that are probably toxic to the cells. This augmentation cannot be 
considered statistically significant, since even though there was a slight difference between 
stimulated I329L lentivirus-transduced IPAM cells and stimulated IPAM cells, this difference 
is insignificant once we compare the levels of superoxide production in I329L lentivirus-
transduced IPAM cells and empty lentivirus-transduced IPAM cells. 
Since I329L has been demonstrated to inhibit TLR3 responses, it could be expected that its 
expression would suppress the recognition of poly(I:C) by this receptor. This would lead to 
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the observation of a reduced or even an absence of response, reflected by a decrease in 
superoxide production, once cells expressing the gene were stimulated with poly(I:C). Thus, 
the results obtained cannot at the moment be explained. 
Also, in terms of cytokine expression we observed no difference between the three cell lines 
upon poly(I:C) stimulation. Even though results in our lab have shown that I329L inhibits 
production of IFN-β as measured by an IFN-β reporter luciferase assay, we still observed 
IFN-β expression in I329L lentivirus-transduced cells stimulated with poly(I:C). Despite these 
results, one must take into account that, this system is not the same as a luciferase assay, 
where only transfected cells are analysed. In contrast, in lentivirus infection as the green 
protein is expressed independently and not as a fusion protein to I329L, all the cells are being 
analysed whether they do or do not express I329L. Finally, it may be that IPAM cells are not 
appropriate for this investigation as they correspond to immature rather than mature 
macrophages. 
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4) CONSTRUCTION OF A TRANSGENIC MOUSE SELECTIVELY EXPRESSING 
I329L IN MACROPHAGES 
 
4.1) INTRODUCTION 
The construction of transgenic mice is considered a powerful strategy for the better 
understanding of the functions of proteins involved in health and disease. As an added 
refinement, the use of specific promoters for a restricted cellular expression may overcome 
undesirable effects such as lethality or whole body transgenesis. 
For millions of years viruses have been co-evolving with their hosts as they develop strategies 
that allow them to manipulate host cell biology, for example cellular processes such as cell 
division, apoptosis, inflammation, interferon and acquired immune responses  3, 4, 13, 54, 89, 106. 
For this reason, virus host evasion genes provide ready made tools to explore and manipulate 
the regulation of these basic cellular processes. Based on this idea, we have constructed a 
transgenic mouse with a macrophage restricted expression of a viral gene that shares 40% 
homology with the highly conserved C terminal domain of mammalian Toll like receptors 
(TLRs), the I329L gene of the African Swine Fever Virus (ASFV), and which has been 
demonstrated to inhibit signalling via TLR3 (our unpublished work). 
We considered that the construction of this transgenic mouse would be useful to observe the 
impact of the expression of I329L specifically in the target cell of the African swine fever 
virus, the macrophage, and might in addition serve as a model for gene therapy. Critical to 
this objective is the requirement for I329L to function in murine cells as well as those of the 
natural host, the pig. Several studies have been performed in our lab, which suggest that the 
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ASFV gene I329L should be functional at the level of a mouse cell. For example,the original 
demonstration of inhibition of TLR signalling done in our laboratory by Vívian Oliveira, was 
performed in Vero (monkey) cells. In addition, Sílvia Almeida has successfully constructed a 
T cell restricted transgenic mouse, expressing A238L, an ASFV gene that inhibits 
transcription mediated by NF-κB and NFAT 65, 66, 75, 76. This mouse developed a 
transplantable, angiogenic thymic tumour, consisting of CD4
+
CD8
+
CD69
- 
(mono-) 
oligoclonal lymphoblasts, with uncontrolled growth in the thymus and metastasis to both the 
secondary lymphoid organs (spleen and lymph nodes) and non-lymphoid tissues, such as 
kidney, lung and liver. In addition, inhibition of TLR signalling I329L has been observed in 
Vero (monkey) cells and as demonstrated in this thesis, mouse macrophages. 
Moreover, the TLRs are evolutionarily conserved molecules reflecting their extreme 
importance in the innate immune system and raising the probability that virus counter 
measures will be equally conserved, a property which is emphasized by the fact that I329L 
function is not limited to pig cells, thus permitting the possible application of this ASFV gene 
to other species. 
 
4.1.1) Lenti-SP-EGFP, a synthetic promoter for Macrophage gene therapy 
Macrophages differentiate from hematopoietic stem cells in bone marrow and are recruited to 
most tissues of the body. There are several factors that make macrophages suitable vehicles 
for the delivery of therapeutic genes: (1) the accessibility of hematopoietic stem cells (2) the 
range of locations to where macrophages are recruited and (3) their intrinsic biosynthetic 
capacity 22. 
For macrophage gene therapy, hematopoietic stem cells are mobilized from bone marrow, 
isolated by apheresis, and transduced ex vivo to establish the stable integration into a 
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chromosome of an expression cassette with the gene(s) of choice. After being autologously 
reinfused, these transduced hematopoietic stem cells  form various lineages of blood cells, 
including macrophages 8, 91. Because they are under the control of macrophage-specific 
promoters, the therapeutic genes should only be expressed at high levels in macrophages. So, 
strong macrophage promoters are valuable tools for this potentially therapeutic strategy 39. 
Several macrophage promoters have been characterized such as the sheep visna virus long 
terminal repeat 12, the microsialin (CD68) promoter 57, the chicken lysozyme minigene 
construct 99, and the scavenger receptor-A (SA) promoter 43. However, these native 
macrophage promoters may not be strong and/or specific enough for the purpose of gene 
therapy. For this reason efforts have been made to create synthetic promoters with high levels 
of activity in skeletal muscle for potential therapeutic advantage 58. The development of a 
synthetic myeloid-specific promoter has been described. This promoter is small in size, has 
high-level macrophage selective activity, and can be used successfully in lentiviral vectors to 
transduce hematopoietic stem cells, leading to sustained expression of the transgene in 
transplanted animals 39. 
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4.2) METHODS AND MATERIALS 
4.2.1) Cell lines 
RAW 264.7 cells (Mouse leukaemic monocyte macrophage cell line) were cultured in RPMI 
1640 with glutamine medium supplemented with 10% Fetal Calf Serum (FCS, heat 
inactivated), 100 Units/mL Penicillin, 100 μg/mL Streptomycin, and 1 mM sodium pyruvate 
all purchased from Gibco, Invitrogen Corporation. 
Cells were routinely checked for contamination with mycoplasm by performing a specific 
PCR. 
 
4.2.2) Luciferase reporter Assays 
The reporter plasmid for the IFN-β promoter [pIF∆(-125/+72)lucter], the reporter plasmid for 
NF-κB [p(PRD2)5tk∆(-39)lucter], and the TK TATA only reporter [ptk∆(-39)lucter] were 
gifts of Dr. S. Goodbourn. The pCMVβ plasmid contains a β-galactosidase gene under the 
control of human cytomegalovirus immediate early promoter, and serves as an internal 
control for culture to culture variations in transfection efficiency. 
A mouse macrophage cell line, RAW 264.7 cells, (6x104 cells/well, in a 24 well plate) was 
co-transfected with 100ng of reporter plasmid, 25 ng of the β-galactosidase internal control 
plasmid (pCMVβ) and 300ng of either pcDNA3HA-I329L, or the empty pcDNA3HA, 
according to the FuGENE HD protocol (Roche). Forty eight hours post-transfection the cells 
were either stimulated or not stimulated with 25μg/ml Poly (I:C) for five hours. After the 5 
hour stimulus the cells were lysed. The luciferase activity was measured using the luciferase 
assay system (Promega) according to the manufacturer`s protocol. The variations in the 
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transfection efficiency between different cells were corrected by dividing luciferase values by 
β-galactosidase values. 
 
4.2.3) Mice 
FVB/N mice were kept at the Animal House facility of the Instituto Gulbenkian de Ciência 
(Oeiras, Portugal), and all experimental procedures involving animal manipulation were 
according to the Direcção Geral de Veterinária de Portugal. 
 
4.2.4) Gene amplication and Construction of the Lenti-SP-I329L-myc plasmid 
The I329L gene was amplified by PCR from DNA of Ba71v, a non-pathogenic strain of 
ASFV that is adapted to grow in Vero cells. We used Pfu DNA Polymerase and the following 
three sets of primers/oligonucleotides: I329LupEcoRIAgeI, 5’-GCGAATTCACCGG 
TATGCTAAGGGTTTTCATA-3’, I329LlowXhoI, 5’-GCCTCGAGCTTTCTTCTTGAAC 
ATGA-3’, and I329LlowAgeIBsrGI, 5’-GCACCGGTTGTACATCACAGATCCTCTTCTGA 
GATGAGTTT-3’. PCR was performed on a PTC-100 Peltier-Effect Cycling apparatus using 
the following conditions: dNTPs 200 µM, primers 1 µM, MgSO4 2 mM, 94ºC – 4’, 30X 
(94ºC–1’, 50ºC–1’, 72ºC–2’), 72ºC–10’. I329LupEcoRIAgeI and I329LlowXhoI primers 
were used to amplify I329L and clone it as a 5’EcoRI-3’XhoI fragment into pcDNA4/Myc-
His Version A (Invitrogen), in order to get a Myc tag. Then, pcDNA4-I329L-Myc-His was 
used on a second PCR, using I329LupEcoRIAgeI and I329LlowAgeIBsrGI primers. The 
construct was sequenced to confirm sequence fidelity and then, I329L-myc was removed 
from pcDNA4 and sucloned as a 5’AgeI-3’BsrgI fragment into Lenti-SP. Lenti-SP-EGFP 
plasmid was kindly sent by Dr. Senlin Li (University of Texas Health Science Center at San 
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Antonio). This plasmid contains synthetic promoter elements, known to be highly active in 
myeloid cells, along with a minipromoter (SP+), and has been reported to drive high levels of 
expression in human and mouse myeloid/macrophage cell lines 39. 
I329L was cloned into this plasmid in order to be under the control of this synthetic 
macrophage specific promoter. 
 
 
Figure 19 - Schematic view of the Lenti-SP-EGFP synthetic plasmid, with 
the known restriction sites 
 
The recombinant vector was digested with EcoRI and BsrGI to release the expression cassette 
from the bacterial backbone pGL3-Basic vector (Promega, Madison, WI). The final construct 
of the transgenic cassette was according to Figure scheme 20. 
 
 
Figure 20 - Schematic view of the microinjected Lenti-SP-I329L-myc construct 
 
After purification, the cassette was delivered to the Transgenic Unit of the IGC where it was 
microinjected into FVB/N fertilized eggs, which were then transferred into pseudo-pregnant 
NMRI foster females. 
Lenti-SP Promoter I329L 
EcoRI AgeI BsrGI 
myc
Lenti-SP Promoter EGFP 
EcoRI AgeI BsrGI 
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Founder mice were crossed with wild-type FVB/N mice to obtain hemizygous mice. 
 
4.2.5) Sequencing 
Sequencing was done to confirm the fidelity of the amplified gene sequence, using primers 
that comprised part of the gene sequence: I329LseqMiddleUp, 5’-TACCTATATTAC 
AATAATCTAA-3’ and I329LseqMiddleLow, 5’-ACTGCGGAAGACGCTTTAGGT-3’. The 
kit used was BigDye terminator v1.1, Part Nr 4336776, Applied Biosystems and the PCR 
conditions were 96ºC-1’ and 25X (96ºC-10’, 50ºC-5’’, 60ºC-4’). The PCR products were 
analysed on a 377 DNA Sequencer and 3130xl Genetic Analyser, Applied Biosystems.  
 
4.2.6) Mouse genotyping by PCR 
Mice were routinely genotyped by PCR using DNA from tail biopsies obtained at the time of 
weaning (3 weeks old). Tails were digested in Laird´s buffer (100 mM Tris.Cl pH 8.5, 5 mM 
EDTA, 0.2 % SDS, 200 mM NaCl) with Proteinase K (100 μg/ml) and then DNA was 
precipitated with isopropanol (0.7 volumes) at RT.  
Detection of the complete I329L gene in the DNA by PCR was performed using Taq DNA 
Polymerase and the following primers: I329Lup, 5’-GCTACTTCTTCTTGAACATGA-3’ and 
I329Llow, 5’-GCTTAGGAAGTGGCTTAACAGG-3’ and PCR conditions were dNTPs 200 
µM, primers 1 µM, MgCl2 2 mM, 94ºC – 4’, 30X (94ºC–1’, 50ºC–1’, 72ºC–2’), 72ºC–10’. 
 
4.2.7) Culture of transgenic macrophage cells 
Macrophage cells were obtained through peritoneal lavage of transgenic and control mice. 
The mice were sacrificed and PBS was injected into their peritoneal cavity. Afterwards, the 
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PBS containing peritoneum cells was collected and the cells were recovered by centrifugation 
at 1200 rpm for 5 minutes. The cell pellet was resuspended in RPMI 1640 with glutamine 
medium supplemented with 10% Fetal Calf Serum (FCS, heat inactivated), 100 Units/mL 
Penicillin, 100 μg/mL Streptomycin, and 1 mM sodium pyruvate all purchased from Gibco, 
Invitrogen Corporation. The cells were cultured for 24 hours, and the macrophages were 
easily separated from the other cells by their adherence to the tissue culture plastic plates and 
the removal of non-adherent cells by washing, as described by Whitthall and Parkhouse, 
1997. 
 
4.2.8) Demonstration of transgene expression by RT-PCR 
Total RNA was extracted from brain, thymus, heart, lung, liver, spleen, kidney and 
macrophages (obtained through peritoneal lavage) of transgenic and control mice using Trizol 
Reagent (Sigma). Samples of RNA were digested with DNaseI (Invitrogen) and cDNA 
synthesis was performed with MMLV-Reverse Transcriptase (Invitrogen), according to the 
manufacturer’s instructions. Detection of the complete I329L gene in the cDNA was 
performed by PCR using Taq DNA Polymerase, on a PTC-100 Peltier-Effect Cycling 
apparatus. Primer sequences were I329Lup, 5’-GCTACTTCTTCTTGAACATGA-3’ and 
I329Llow, 5’-GCTTAGGAAGTGGCTTAACAGG-3’ and PCR conditions were dNTPs 200 
µM, primers 1 µM, MgCl2 2 mM, 94ºC – 4’, 30X (94ºC – 1’, 50ºC – 1’, 72ºC – 2’), 72ºC – 
10’. As a quantitative and qualitative control, tubulin was amplified using Taq DNA 
Polymerase with dNTPs 200 µM, primers 1 µM, MgCl2 2 mM, 94ºC – 4’, 40X (94ºC – 1’, 
55ºC – 1’, 72ºC – 2’), 72ºC – 10’. Tubulin primer sequences were the following: TubulinUp, 
5’-GGTGGATCTAGAACCTGGG-3’ and TubulinLow, 5’-CCCAGTGAGTGGGTCAGC-
3’.
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4.3) RESULTS 
4.3.1) Confirmation of the impact of I329L on a mouse macrophage cell line 
Due to previous results in our lab regarding this gene and other genes of ASFV, it was our 
prediction that I329L would be functional at the level of the mouse cell. In order to test this 
prediction, we used a mouse macrophage cell line (RAW 264.7) focusing on two relevant 
transcription factors (IFN-β and NF-κB (PRD2)) and performed luciferase reporter assays on 
I329L transfected RAW 264.7 cells given a poly(I:C) stimulus. 
A clear response of these cells to poly(I:C) was observed in control cultures. When I329L was 
transfected into the cells, however, this response decreased dramatically (Figure 21). Thus the 
ASFV gene I329L functions at the level of the mouse cell and so the construction of the 
I329L transgenic mouse was commenced. 
0.00
5.00
10.00
15.00
20.00
25.00
30.00
INFβ + Empty INFβ + I329L
Medium
Poly I:C
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
NFκB + Empty NFκB + I329L
Medium
Poly I:C
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
TK  + Empty TK  + I329L
Medium
Poly I:C
 
Figure 21 – I329L inhibits RAW 264.7 cell response to poly(I:C). 
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Figure 21 – I329L inhibits RAW 264.7 cell response to poly(I:C). The graphs 
show that I329L transfected cells have a decreased response to poly(I:C) 
stimulation, in comparison with empty plasmid transfected cells. This decrease is 
observed either using IFN-β and NF-κB (PRD2) luciferase reporter genes. TK 
minimal promoter was used as a negative control for luciferase. 
 
4.3.2) PCR analysis of transgenic mice 
One transgenic mouse, a male, was obtained from a litter of a total of eleven mice (five males 
and six females), after injection of fertilized eggs with the expression cassette of the Lenti-SP 
plasmid containing the I329L transgene and a downstream Myc immunotag. 
The founder mouse was crossed with wild type FVB/N females in order to obtain F1 litters. 
Transgene expression was determined by PCR (Figure 22A). We observed that the founder 
mouse transmitted the transgene, since 7/10 animals were positive by PCR (Figure 22B). 
12   13  14   15   16   17  18   19   20   21
I329L
F1 litter
I329L
Founder litter
1     2     3    4     5     6     7     8     9    10    11
A
B
 
Figure 22 – PCR analysis of the founder and F1 litter mice of the I329L 
macrophage restricted transgenic line. A) After microinjection of the 
expression cassette, the litter was analysed by PCR, and one transgenic mouse 
was detected (number 5). B) The founder transgenic mouse (number 5) was then 
crossed with wild type females to obtain an F1 litter, that was also genotyped. In 
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the F1 litter we obtained 7 transgenic mice (numbers 12, 14, 16, 18, 19, 20 and 
21) out of 10. 
 
4.3.3) Proof of macrophage restricted transgene expression 
Wild type and transgenic mice were sacrificed and their peritoneal cavities were washed with 
PBS in order to obtain macrophages. After purifying the macrophages, as described, RNA 
was extracted from them and a cDNA copy was prepared corresponding to the sequence of 
the I329L transgene. 
I329L expression was only observed in macrophages of transgenic mice, and not in wild type 
mice (Figure 23A). 
To confirm that I329L expression was specific to macrophages, wild type and transgenic mice 
were sacrificed and their brain, thymus, heart, lung, liver, spleen and kidneys were dissected. 
RNA was extracted and cDNA was synthesized for each sample. We observed no I329L 
expression in any of the wild type or transgenic organs. (Figure 23C). 
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Figure 23 – Expression of I329L is specific in macrophages collected from 
the I329L restricted transgenic mouse line. A) RT-PCR for the I329L gene is 
negative for wild type macrophages (lane 1), I329L specific expression was 
Chapter IV 
 
 
Ana Catarina Mota Correia 
69 
detected in macrophages of I329L transgenic mice (lane 2). B) PCR for tubulin, 
as a control of the quantity and quality of the cDNAs. C) RT-PCR is negative for 
the I329L gene in brain (Br), thymus (Th), heart (He), lungs (Lu), liver (Li), 
spleen (Sp) and kidneys (Kd) of wild type mice. D) RT-PCR is negative for the 
I329L gene in brain (Br), thymus (Th), heart (He), lungs (Lu), liver (Li), spleen 
(Sp) and kidneys (Kd) of I329L transgenic mice. 
Tubulin was amplified as a control of the quantity and quality of the cDNAs. 
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4.4) DISCUSSION 
Viruses have been exploiting the cell biology of their hosts for millions of years. The 
strategies so evolved not only provide new insight into our systems and into the pathogenesis 
of infection, but also provide ready made tools for genetic manipulation and provide an 
alternative to the established procedures for constructing conventional transgenic and gene 
deletion mutant eukaryotic organisms, for probing the properties of virus host evasion genes, 
and for manipulating the genetic programme of mammalian cells in vivo. This novel strategy 
to modify and/or manipulate gene expression in mouse models using virus host evasion genes 
constitutes the basis of the construction of an I329L macrophage restricted expression mouse, 
an African swine fever virus (ASFV) gene manipulating signaling via TLRs. 
Prior to developing the macrophage restricted I329L transgenic mouse, we proved that this 
gene was functional at the level of a mouse macrophage. A mouse macrophage cell line 
(RAW 264.7 cells), was transfected with a plasmid containing the I329L gene and, after a 
poly(I:C) stimulus, luciferase reporter assays were done using IFN-β and NF-κB-driven 
luciferase reporters. The RAW 264.7 cells were observed to respond to poly(I:C) stimulus 
with a stimulation of both reporters. Significantly, when a plasmid containing I329L was 
transfected into cells, there was a clear decrease in the response with both reporters. These 
results conclusively demonstrated that I329L is functional in a mouse macrophage and 
emphasized the conserved nature of the TLR system and the corresponding virus strategy for 
its subversion. 
In order to construct this transgenic mouse we used a plasmid constructed by Dr. Senlin Li 
(University of Texas Health Science Center at San Antonio), that has a synthetic promoter 
specific for macrophages. Since ASFV infects macrophages and the I329L gene inhibits 
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signal transduction for TLR3, the development of this transgenic mouse cell line is a rational 
approach to determine the impact of this individual gene on macrophage cell biology. The 
observation of the effect of the gene in vivo together with the findings in vitro, may contribute 
to our understanding of both the function of I329L and the innate immune response. 
After I329L was cloned into this plasmid, the cassette was prepared and microinjected into 
mouse oocytes. One transgenic male founder mouse was obtained which was crossed with 
wild type mice in order to obtain F1 mice. As expected, the transgene was transmitted to the 
F1 offspring. The next logical step was to check that I329L was indeed being specifically 
expressed by macrophages, as predicted by the promoter construct. Thus, macrophages 
obtained through peritoneal lavage and other tissues of wild type and transgenic mice were 
tested for transgene expression at the mRNA level by RT-PCR. While brain, thymus, heart, 
lungs, liver, spleen and kidney from wild type and transgenic mice were negative, there was 
expression of the transgene by transgenic, but not wild type macrophages. As some of the 
organs examined do contain macrophages we may assume that they are not present in 
sufficient amounts to be detectable by the RT-PCR proceeding, whereas pure macrophage 
populations were, as stated above, positive. 
The construction and analysis of a transgenic mouse is a complex process, time consuming 
and technically challenging. Much now still remains to be analysed in these transgenic mice, 
for example the integrity of the expression cassette and functional assays in the transgenic 
macrophages (see chapter 3) intact mice. Unfortunately, this work will now pass to another 
member of the group. Studies for the future will include the response of these transgenic 
macrophages to different stimuli in vitro, for example by upregulation of MHC Class II and 
production of NO. As an assessment of the impact of the transgene in vivo, infection models 
such as tuberculosis (a disease in which the bacteria replicates in macrophages), or the mouse 
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γ herpesvirus MHV68 which also infects macrophages 41, as well as B cells may be 
considered. 
 
Chapter V 
 
 
Ana Catarina Mota Correia 
73 
 
5) FINAL CONCLUSIONS 
Viruses have been exploiting the cell biology of their hosts for millions of years. The 
strategies so evolved not only provide new insight into our systems and into the pathogenesis 
of infection, but also constitute ready made tools for genetic manipulation and thus an 
alternative to the established procedures for constructing conventional transgenic and gene 
deletion mutant eukaryotic organisms. 
IFN and TLR responses are very important for innate immunity against viruses, and its 
inhibition confers and advantage to the virus, allowing it to survive and replicate. Viral 
evasion genes constitute suitable tools for the understanding and manipulation of host-
pathogen interaction, allowing the development of new strategies for the control of viral 
infections, non-infectious diseases such as cancer, inflammatory diseases, and for gene 
therapy. Also, the elimination of viral evasion genes appears to be a suitable approach in the 
development of attenuated vaccines. 
We have proved in this thesis, that the I329L gene is a non-essential gene of the ASFV and 
begun the construction of an I329L deletion-virus mutant. Also, we have demonstrated that 
this gene functions in mouse macrophages (a cell type which the virus infects in its natural 
porcine host) and constructed an I329L macrophage restricted-expression transgenic mouse. 
The combined properties of the I329L deletion-mutant and the I329L restricted transgenic 
mouse will provide excellent systems to study the mechanism of action and possible utility of 
I329L through transcription profiles and infection models. 
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